Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
   volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             2132 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Aβ amyloid, cognition and APOE genotype in the preclinical stages of Alzheimer's disease Ellis, Kathryn
2012
8 4S p. P556-P557
artikel
2 ABCA7 and MS4A6A expression are upregulated in Alzheimer's disease brains Jeng, Amanda
2012
8 4S p. P663
artikel
3 ABCA1 deficiency differentially affects the amyloid phenotype of APOE-ε3- and APOE-ε4-targeted replacement mice Lefterov, Iliya
2012
8 4S p. P718
artikel
4 ABCA-1-mediated beta-amyloid uptake by cells of the blood-brain barrier Biemans, Elisanne A.L.M.
2012
8 4S p. P641
artikel
5 Aβ binding properties of a synthetic peptide corresponding to an amino acid sequence in human pericentriolar material 1 (PCM-1) protein Chakravarthy, Balu
2012
8 4S p. P469
artikel
6 A biomarker signal: Context-dependent hippocampal fMRI connectivity analysis of clinical trial measures in Alzheimer's disease McLaren, Donald
2012
8 4S p. P19
artikel
7 A biomarker signal: Context-dependent hippocampal fMRI connectivity analysis of clinical trial measures in Alzheimer's disease McLaren, Donald
2012
8 4S p. P331
artikel
8 A blood-based gene expression test to detect prodromal Alzheimer's disease Sjogren, Magnus
2012
8 4S p. P433-P434
artikel
9 Absence of BETA-AMYLOID oligomers at mitochondria in the hippocampus of individuals with Alzheimer's disease neuropathology who remain cognitively intact Taglialatela, Giulio
2012
8 4S p. S783
artikel
10 Absence of beta-amyloid oligomers at synapses parallels increased insulin signaling in the hippocampus of nondemented individuals with severe Alzheimer's neuropathology Taglialatela, Giulio
2012
8 4S p. P448
artikel
11 Abusive behaviors in the caregivers of dementia patients: Results from the Nationwide Survey on Dementia Care in Korea (NaSDECK) Kim, Ki Woong
2012
8 4S p. P249-P250
artikel
12 A case of apparently reversible Alzheimer's disease Clionsky, Emily
2012
8 4S p. S755
artikel
13 A case of cognitive impairment with delayed onset of parkinsonism after industrial gas intoxication Park, Mee
2012
8 4S p. S778
artikel
14 A case of familial CJD with a PRNP E200K mutation Kwon, Yooseok
2012
8 4S p. P684
artikel
15 Accelerated neurodegeneration and phenotypic switch of neuroinflammation in transgenic mice expressing P301L tau-mutant and tau-tubulin kinase 1 Asai, Hirohide
2012
8 4S p. P309
artikel
16 Acceptability, safety and feasibility of aerobic exercise in patients with mild-to-moderate ALZHEIMER'S disease: A pilot study Frederiksen, Kristian
2012
8 4S p. P715-P716
artikel
17 Accuracy of different biomarkers to predict progression from mild cognitive impairment to probable Alzheimer's dementia in two independent clinical series Prestia, Annapaola
2012
8 4S p. P158-P159
artikel
18 Accurate intracranial cavity volume estimation using multiatlas segmentation Schaerer, Joël
2012
8 4S p. P272
artikel
19 A cell-based model for presenilin 1 early-onset familial Alzheimer's disease (EOFAD): Dominant negative effects and relative stabilities of presenilin 1 with EOFAD mutations Stevens, Anthony
2012
8 4S p. P242
artikel
20 A chorus for older adults with dementia and their family members: Results of a pilot study Mittelman, Mary
2012
8 4S p. S773
artikel
21 A clinical study on event-related potential N400 in patients with Alzheimer's disease and mild cognitive impairment Ning, Su
2012
8 4S p. P177
artikel
22 A comparative assessment of approaches to develop and evaluate novel endpoints for Alzheimer's disease trials Raghavan, Nandini
2012
8 4S p. P368
artikel
23 A comparative study on the effectiveness of a cognitive intervention program in patients with cognitive impairment secondary to acquired brain damage and neurodegenerative disease Demey, Ignacio
2012
8 4S p. P571
artikel
24 A comparison of crossover versus parallel-arm clinical study designs in evaluating the psychomotor and cognitive deficits induced by scopolamine Leurent, Claire
2012
8 4S p. S771
artikel
25 A comparison of hippocampal atrophy algorithms to select outcome measures for clinical trials in mild-to-moderate Alzheimer's disease Burns, Leah
2012
8 4S p. P408
artikel
26 A comparison of methods for deriving normative scores for evaluating cognitive impairment Pirraglia, Elizabeth
2012
8 4S p. P541-P542
artikel
27 A composite diagnostic index for Alzheimer's disease using plasma beta-amyloid (1-42): A preliminary study Kim, Tae Hui
2012
8 4S p. P269
artikel
28 A convergence between items on the Montreal Cognitive Assessment and neuropsychological tests in mild cognitive impairment: A factor analysis Frtusova, Jana
2012
8 4S p. P360
artikel
29 A critique of the extant criteria for vascular cognitive disorders and a proposal Sachdev, Perminder
2012
8 4S p. P726-P727
artikel
30 A cross-national examination of the association between behavioral, psychological, cognitive and functional symptoms on quality of life of people with Alzheimer's disease Duhig, Amy
2012
8 4S p. P250
artikel
31 A cross-national study of augmentation of cholinesterase inhibitors with memantine in Alzheimer's disease Duhig, Amy
2012
8 4S p. P707
artikel
32 A cross-national study of carer burden in dementia Duhig, Amy
2012
8 4S p. P378
artikel
33 Action (verb) fluency and action naming in Alzheimer's disease and normal aging: Preliminary data from a Brazilian study Beber, Bárbara
2012
8 4S p. P538-P539
artikel
34 Activation and alteration of lysosomes in multiple system atrophy Makioka, Kouki
2012
8 4S p. P174
artikel
35 Activation of estrogen receptor beta promotes IRS/PI3K/AKT/GSK3B-mediated insulin signaling in the female brain: Implications for anti-aging and Alzheimer's prevention Zhao, Liqin
2012
8 4S p. P645
artikel
36 Activation of NLC4 inflammasome in primary rat astrocytes by palmitate enhances Alzheimer's disease–like changes in primary neurons Liu, Li
2012
8 4S p. P302
artikel
37 Active immune intervention for prionoses in deer Wisniewski, Thomas
2012
8 4S p. P403-P404
artikel
38 Active immunomodulation targeting abnormal conformation for the treatment of multiple neurodegenerative diseases Goni, Fernando
2012
8 4S p. P625
artikel
39 Activity of P-glycoprotein, an ABC efflux transporter at the blood-brain barrier, is compromised in Alzheimer's disease Deo, Anand
2012
8 4S p. P698
artikel
40 Acute functional and morphological impact of Aß oligomers Epelbaum, Stéphane
2012
8 4S p. P297
artikel
41 ADAS-cog: Rationale for computerized cognitive testing Veroff, Amy
2012
8 4S p. P538
artikel
42 A data-derived Aβ biomarker model computed using longitudinal PIB data from AIBL Thurfjell, Lennart
2012
8 4S p. P452-P453
artikel
43 ADCS data sharing Thomas, Ronald
2012
8 4S p. P590
artikel
44 ADCS EDC Jimenez-Maggiora, Gustavo
2012
8 4S p. P584
artikel
45 Added value of 11C-PiB-PET imaging in the diagnosis of Alzheimer's disease Frederiksen, Kristian
2012
8 4S p. P14-P15
artikel
46 Added value of 11C-PiB-PET imaging in the diagnosis of Alzheimer's disease Frederiksen, Kristian
2012
8 4S p. P162
artikel
47 A DDT metabolite is elevated in the serum of Alzheimer's disease patients German, Dwight
2012
8 4S p. P496
artikel
48 ADNI structural imaging markers are applicable to a community-based Chinese cohort Tan, Ming Zhen
2012
8 4S p. P524-P525
artikel
49 Adult neurogenesis is diminished in a novel rat model of Alzheimer's disease Breunig, Joshua
2012
8 4S p. P409-P410
artikel
50 Advancement of a drug-disease trial model for Alzheimer's disease through a regulatory science path: The CAMD experience Romero, Klaus
2012
8 4S p. P587-P588
artikel
51 Aerobic exercise versus stretching and toning: Changes in physical function and mediation of cognitive effects in the MAX Trial Middleton, Laura
2012
8 4S p. P146
artikel
52 A feasibility study of speech recording using a contact microphone in patients with possible or probable Alzheimer's disease to detect and quantify repetitions in a natural setting Nemes, Vanda
2012
8 4S p. P490-P491
artikel
53 A five-way crossover study to evaluate the single-dose effects of a novel 5-HT6 receptor antagonist, PF-07212377 (SAM-760), on reversing psychomotor and cognitive deficits induced by scopolamine Bell, Joanne M.
2012
8 4S p. S792
artikel
54 Age and APOE-ɛ4 Effects on rates of clinical and structural decline in ADNI participants Holland, Dominic
2012
8 4S p. S765
artikel
55 Age-associated memory impairment increases risk of conversion to MCI and dementia Lee, Grace
2012
8 4S p. P544
artikel
56 Age-associated trajectories of biomarkers in early-onset Alzheimer's disease, for the Alzheimer's Prevention Initiative Chen, Kewei
2012
8 4S p. P85
artikel
57 Age correlates with cortical acetylcholinesterase decline in Alzheimer's disease patients: A PET study Hirano, Shigeki
2012
8 4S p. P51-P52
artikel
58 Age correlates with cortical acetylcholinesterase decline in Alzheimer's disease patients: A PET study Hirano, Shigeki
2012
8 4S p. P531-P532
artikel
59 Age-dependent expression of a dominant negative splice variant of estrogen receptor beta in the hippocampus of women Reddy, Raveena
2012
8 4S p. P410
artikel
60 Age-dependent increase in Aß deposition in the nasal cavity of a transgenic mouse model of Alzheimer's disease Kameshima, Naoko
2012
8 4S p. P298
artikel
61 Ageing and Alzheimer's disease in Iran: A growing problem for family and society Sheykhi, Mohammad Taghi
2012
8 4S p. S781
artikel
62 Ageing increases vulnerability to Aβ42 toxicity in drosophila Kerr, Fiona
2012
8 4S p. P202
artikel
63 Age-related differences in functional connectivity of resting-state EEGs in Alzheimer's disease de Waal, Hanneke
2012
8 4S p. P691
artikel
64 Age-related memory decline is mediated by processing speed and myelin integrity Lu, Po-Haong
2012
8 4S p. P516
artikel
65 Age-related modulation of gamma-secretase activity in monkey brains Nishimura, Masaki
2012
8 4S p. P295
artikel
66 Age-related reductions in T-type calcium channels and their contribution to Alzheimer's disease pathogenesis Rice, Rachel
2012
8 4S p. P292-P293
artikel
67 Aggregation and size-dependent uptake and transport of tau aggregates in neurons Wu, Jessica
2012
8 4S p. P97
artikel
68 Aging, amyloid and neural activity Jagust, William
2012
8 4S p. P427
artikel
69 A high level of neuroticism in early-stage Alzheimer's disease is associated with an increased risk of later developing behavior disorders Dorey, Jean-Michel
2012
8 4S p. P355
artikel
70 A human NH2-tau fragment contributes to early synaptic degeneration in Alzheimer's disease by increasing mitochondrial autophagy Amadoro, Giuseppina
2012
8 4S p. P304-P305
artikel
71 A human stem cell model of early Alzheimer's disease pathology in Down syndrome Livesey, Rick
2012
8 4S p. P724
artikel
72 AIBL ACTIVE: A randomized controlled trial of physical activity to delay the progression of white matter hyperintensities on MRI in older adults at risk of cognitive decline Cyarto, Elizabeth
2012
8 4S p. P506
artikel
73 AiblWHAP: Methodology and baseline characteristics of a population-based sample recruited for a longitudinal study of risk factors and later-life cognitive decline Grigg, Jasmin
2012
8 4S p. P321-P322
artikel
74 Aβ immunization in old mouse lemur primates induces cerebral microhemorrhages and accelerates age-associated iron deposits in the choroid plexus Dorieux, Olene
2012
8 4S p. P626
artikel
75 Aß influences nicotinic-stimulated release of both excitatory and inhibitory neurotransmitters in rat hippocampus Mura, Elisa
2012
8 4S p. P210-P211
artikel
76 Aß inhibition of kinesin 5 induces neurotransmitter and neurotrophin receptor mislocalization and dysfunction Ari, Csilla
2012
8 4S p. P468
artikel
77 A kindred with familial frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 Wicklund, Meredith
2012
8 4S p. P169
artikel
78 Allele-specific miRNA mediated regulation of APP expression Saunders, Aleister
2012
8 4S p. P421-P422
artikel
79 Allopregnanolone analogues promote proliferation of neural progenitor cells Chen, Shuhua
2012
8 4S p. P401
artikel
80 Allopregnanolone as a regenerative drug candidate in a female mouse model of Alzheimer's disease Zhu, Muye
2012
8 4S p. P398
artikel
81 Allopregnanolone as a regenerative therapeutic for Alzheimer's: Formulation development for clinical trials Irwin, Ronald
2012
8 4S p. P400
artikel
82 A longitudinal diffusion tensor imaging (DTI) study in early Alzheimer's disease (AD) Perea, Rodrigo
2012
8 4S p. P345
artikel
83 A longitudinal fMRI study of cholinergic modulation in nondemented patients with mild memory impairment Pa, Judy
2012
8 4S p. P167
artikel
84 A longitudinal study of aging and the development of Alzheimer's disease in people with Down syndrome Head, Elizabeth
2012
8 4S p. P355-P356
artikel
85 A longitudinal study of the dissociation between implicit and explicit indications of awareness using the emotional Stroop effect for dementia-related words in early stage dementia Clare, Linda
2012
8 4S p. P728
artikel
86 A long-term community investment model for empowering older African-Americans to participate in Alzheimer's disease genetics research Lang, Rosalyn
2012
8 4S p. P377
artikel
87 Alpha-lipoic acid affects memory and lifespan in SAMP8 mice Morley, John
2012
8 4S p. P419
artikel
88 Alterations in connexin 43 phosphorylation during the progression of Alzheimer's disease: Possible role of astrocytic calcineurin Furman, Jennifer
2012
8 4S p. P300
artikel
89 Altered expression of mitochondria-associated membrane (MAM) proteins in tgAPP mutant mouse brain and Alzheimer's disease brain Hedskog, Louise
2012
8 4S p. P307-P308
artikel
90 Altered functional brain network in cognitively normal elderly with genetic high risk for Alzheimer's disease: Graph-theoretical analysis of brain glucose metabolism Seo, Eun Hyun
2012
8 4S p. P56
artikel
91 Altered functional brain network in cognitively normal elderly with genetic high risk for Alzheimer's disease: Graph-theoretical analysis of brain glucose metabolism Seo, Eun Hyun
2012
8 4S p. P685
artikel
92 Altered glycosylation in serum proteins of Alzheimer's disease Taniguchi, Miyako
2012
8 4S p. P119
artikel
93 Altered white matter connectivity and atrophy at hippocampal subregions in Alzheimer's dementia and APOE-ε4 carriers Bagepally, Bhavani
2012
8 4S p. P684-P685
artikel
94 Alzheimer disease and the delay of its diagnosis: Results of an epidemiological study carried out in the Cognition and Behaviour Unit (BCU) of Clinico San Carlos Hospital (HCSC), Madrid, Spain Rodriguez, Octavio
2012
8 4S p. P501
artikel
95 Alzheimer's disease and mild cognitive impairment weaken connections within the default-mode network: A multimodal study with resting-state fMRI, diffusion MRI and FDG-PET Zhu, David
2012
8 4S p. S790-S791
artikel
96 Alzheimer's disease and stroke: A treatable connection? Hachinski, Vladimir
2012
8 4S p. P609
artikel
97 Alzheimer's disease and the Valley of Death: Not enough guidance from human brain tissue? Beach, Thomas
2012
8 4S p. P405
artikel
98 Alzheimer's disease beta-amyloid protein mutations and deletions that define neuronal binding/internalization as early-state nonfibrillar/fibrillar aggregates and late-state fibrils Poduslo, Joseph
2012
8 4S p. P472
artikel
99 Alzheimer's disease human brain beta-amyloid-containing extracts inhibit hippocampal long-term potentiation in rats in vivo: Relationship between soluble and insoluble preparations Klyubin, Igor
2012
8 4S p. P648
artikel
100 Alzheimer's disease instruments validation study in Asia Shen, Joan
2012
8 4S p. P545-P546
artikel
101 Alzheimer's Disease International's efforts to make dementia a global health priority Wortmann, Marc
2012
8 4S p. P238-P239
artikel
102 Alzheimer's disease pathology burden associated with clinical dementia decreases with age Silbert, Lisa
2012
8 4S p. P446
artikel
103 Alzheimer's disease patients with adult child study partners are underrepresented in clinical trials and may experience slower cognitive decline Grill, Joshua
2012
8 4S p. P585-P586
artikel
104 Alzheimer's disease patients with microbleeds and additional white matter hyperintensities: Does it matter? Benedictus, Marije
2012
8 4S p. P617
artikel
105 Alzheimer's disease-related changes in plasma brain-derived neurotrophic factor levels: Data from the AIBL study Rainey-Smith, Stephanie
2012
8 4S p. P407-P408
artikel
106 Alzheimer's disease–related changes in plasma cortisol levels and gene involvement in the AIBL study Laws, Simon
2012
8 4S p. P407
artikel
107 Alzheimer's disease–related changes in subfields of the hippocampal formation using 7T MRI Wisse, Laura
2012
8 4S p. P64
artikel
108 Alzheimer's disease: Small molecules as disease-modifying agents Rao, Praveen
2012
8 4S p. P200
artikel
109 Alzheimer's disease–specific changes in cerebral gray matter revealed using a novel voxel-wise approach for constructing structural brain networks Whitlow, Christopher
2012
8 4S p. P60
artikel
110 Alzheimer's disease: Where does atrophy really begin? Whitwell, Jennifer
2012
8 4S p. P420
artikel
111 Alzheimer's disease with age of onset less than 50 years: Genetic determinisms in sporadic cases Wallon, David
2012
8 4S p. P666-P667
artikel
112 Alzheimer's disease with agitation: A genome-wide association study Chapman, Jade
2012
8 4S p. P669
artikel
113 Alzheimer's-related changes in subfields of the hippocampal formation using 7T MRI Wisse, Laura
2012
8 4S p. P695
artikel
114 Alzheimer's-related mortality at eight years' follow-up in a Southern Brazilian population-based cohort: The PALA study Camozzato, Ana Luiza
2012
8 4S p. P494
artikel
115 Alzheimer's risk variants CR1 and apolipoprotein E interact to influence progression of Alzheimer's pathology in nondemented elderly Thambisetty, Madhav
2012
8 4S p. P673
artikel
116 Ambulatory assessment beyond the actigraph: The Voice, Activity and Location Monitoring in Alzheimer's Disease (VALMA) project Rose, Rhiannon
2012
8 4S p. P230
artikel
117 Amnestic mild cognitive impairment in a memory clinic: Longitudinal course and predictors of progression Chertkow, Howard
2012
8 4S p. P482
artikel
118 A model for social behavioral care: Community-based dementia treatment Piersol, Catherine
2012
8 4S p. P430
artikel
119 Amorfix Epitope Protection-Alzheimer's Disease (EP-AD) diagnostic cerebrospinal fluid test for accurate identification of Alzheimer's disease and mild cognitive impairment Scrocchi, Louise
2012
8 4S p. P239
artikel
120 Amtrel Chen, Chun-Hung
2012
8 4S p. P142
artikel
121 A multicenter clinical trial to validate Event-Related Potentials (ERPs) as useful biomarkers for early detection of Alzheimer's Jicha, Gregory
2012
8 4S p. P406-P407
artikel
122 A multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on its atrophy-delaying effect in Alzheimer's disease Lee, Dong Young
2012
8 4S p. P603
artikel
123 A multidimensional effect-size analysis of cholinesterase inhibitors for Alzheimer's disease Peters, Kevin
2012
8 4S p. P587
artikel
124 A multidomain prediction model for mild cognitive impairment to Alzheimer's disease conversion Lee, Sei
2012
8 4S p. P149
artikel
125 A multivariate glucose metabolism metric for patient stratification and prediction of cognitive decline in Alzheimer's disease clinical trials Matthews, Dawn
2012
8 4S p. P43
artikel
126 A multivariate glucose metabolism metric for patient stratification and prediction of cognitive decline in Alzheimer's disease clinical trials Matthews, Dawn
2012
8 4S p. P511-P512
artikel
127 A multivariate portable noninvasive diagnostic approach to actively assess cognitive function in Alzheimer's disease (AD) and mild cognitive impairment (MCI) Simon, Adam
2012
8 4S p. P115-P116
artikel
128 Amyloid burden and neuropsychological performance in presymptomatic first-degree relatives at varying APOE-ɛ4 risk for Alzheimer's disease van Dyck, Christopher H.
2012
8 4S p. P5
artikel
129 Amyloid burden in early-onset versus late-onset Alzheimer's disease: Comparison of two extremes Cho, Hanna
2012
8 4S p. P228-P229
artikel
130 Amyloid burden in early-onset versus late-onset Alzheimer's disease: Comparison of two extremes Cho, Hanna
2012
8 4S p. P173
artikel
131 Amyloid imaging and hippocampal volumes in the classification of prodromal Alzheimer's disease: The ADNI study Duara, Ranjan
2012
8 4S p. P598
artikel
132 Amyloid imaging in at risk cognitively normal individuals and patients with subjective cognitive impairment Chetelat, Gaël
2012
8 4S p. P607
artikel
133 Amyloid imaging in differential diagnosis of Alzheimer's disease dementia Rowe, Christopher
2012
8 4S p. P607
artikel
134 Amyloid imaging in patients with vascular dementia Seo, Sang Won
2012
8 4S p. P607
artikel
135 Amyloid imaging in the multimodal evaluation of MCI Jagust, William
2012
8 4S p. P607-P608
artikel
136 Amyloid PET imaging using AZD4694 and unusually brief radiotracer uptake and scanning periods Chen, Kewei
2012
8 4S p. P10
artikel
137 Amyloid PET imaging using AZD4694 and unusually brief radiotracer uptake and scanning periods Chen, Kewei
2012
8 4S p. P14
artikel
138 Amyloid PET imaging using AZD4694 and unusually brief radiotracer uptake and scanning periods Chen, Kewei
2012
8 4S p. P162
artikel
139 Amyloid precursor protein regulates neuronal cholesterol turnover needed for synaptic activity Pierrot, Nathalie
2012
8 4S p. P648-P649
artikel
140 Amyloid-Related Imaging Abnormalities (ARIA) Sperling, Reisa
2012
8 4S p. P606
artikel
141 An active lifestyle postpones dementia onset by more than one year in very old adults Wang, Hui-Xin
2012
8 4S p. P98-P99
artikel
142 Anaesthesia and dementia: The forgotten association Silbert, Brendan
2012
8 4S p. P424
artikel
143 Anaesthesia, surgery and Alzheimer's disease: Insights from animal models Culley, Deborah
2012
8 4S p. P425
artikel
144 Analysis of Aß levels in nasal smears of patients with Alzheimer's disease Fukuhara, Takaomi
2012
8 4S p. P120
artikel
145 Analysis of Aβ transport in a human blood-brain barrier model Biemans, Elisanne A.L.M.
2012
8 4S p. P207
artikel
146 Analysis of insulin-degrading enzyme (IDE) expression and function in zebrafish embryos Chen, Mengqi
2012
8 4S p. P674
artikel
147 Analysis of physiological α-synuclein by non-denaturing gel electrophoresis Liu, Feng
2012
8 4S p. P470
artikel
148 Analysis of two immune function genes (CR1 and CD2AP) in Alzheimer's disease in two large Canadian cohorts Omoumi, Ardeshir
2012
8 4S p. P722
artikel
149 An Alzheimer's disease dysexecutive subgroup demonstrates slower cognitive decline than an amnestic subgroup in the National Alzheimer's Coordinating Center database Mez, Jesse
2012
8 4S p. P635-P636
artikel
150 An APP translation modulator ARN2966 reduces BETA-AMYLOID deposition and prevents memory deficits in ALZHEIMER'S DISEASE transgenic mice Asuni, Ayodeji
2012
8 4S p. S744
artikel
151 Anatomical correlate of closing-in phenomenon Yang, Dong Won
2012
8 4S p. P43-P44
artikel
152 An automated and robust algorithm to measure changes in medial temporal lobe volume in early Alzheimer's disease Kazemifar, Samaneh
2012
8 4S p. P345-P346
artikel
153 An evidence-based review: Donepezil HCl in the treatment of Alzheimer's disease Alsalamah, Abrar
2012
8 4S p. P709
artikel
154 A new in vitro functional assay on primary cortical cultures shows that PPAR-gamma agonists are neuro-protective against MPP+ but not beta-amyloid-induced synaptotoxicity Kiss, Andrea
2012
8 4S p. P648
artikel
155 A new level of operational complexity within innovative Alzheimer's disease trial designs: Case study of a phase 2 bapineuzumab trial—SUMMIT-AD Guthrie, Spencer
2012
8 4S p. P590-P591
artikel
156 A new MR-based quantitative measure of fine cortical texture for monitoring of Alzheimer's disease progression James, Kristin
2012
8 4S p. S765-S766
artikel
157 A new pathogenic pathway and causative treatment option for Alzheimer's disease: From aging to mitochondrial and ABC transporter dysfunction Krohn, Markus
2012
8 4S p. P86
artikel
158 Angiotensin-converting enzyme inhibitors and the calcium channel blocker Chen, Chun-Hung
2012
8 4S p. P220
artikel
159 Angiotensin-converting enzyme polymorphism in combination with MTHFR or APOE-ε4 genotype and white matter hyperintensities in Alzheimer's dementia Kang, Heeyoung
2012
8 4S p. P685
artikel
160 Anhedonia is associated with the risk of Alzheimer's disease in elders with mild cognitive impairment: Results from the Korean Longitudinal Study on Health and Aging (KLOSHA) So, YoonSeop
2012
8 4S p. P594
artikel
161 An immunological epitope specific for toxic oligomeric Aß in Alzheimer's disease Silverman, Judith
2012
8 4S p. P625
artikel
162 An improved cell-based method for determining the gamma-secretase enzyme activity against both Notch and APP substrates McKee, Timothy
2012
8 4S p. P296
artikel
163 An integrated approach to the development of biomarkers for Alzheimer's disease using hospital population data Farnum, Michael
2012
8 4S p. P109
artikel
164 An integrated cognitive rehabilitation multi family group intervention for individuals with mild cognitive impairment and their care partners: Preliminary data Schmitter-Edgecombe, Maureen
2012
8 4S p. P578-P579
artikel
165 An integrated mechanistic model to interrelate CSF Aβ40, Aβ42, sAPPβ and sAPPα response to β- and γ-secretase inhibitors in rhesus monkey Stone, Julie
2012
8 4S p. P202-P203
artikel
166 An interdisciplinary journal club for training in Alzheimer's disease research ethics and responsible conduct of research Williams, Monique
2012
8 4S p. P564
artikel
167 An interlocutory strategy for Alzheimer's disease patients: Spatialization of temporal appropriation Jonveaux, Therese Rivasseau
2012
8 4S p. S779
artikel
168 An investigation of mitochondrial oxidative stress in Alzheimer's disease Majid, Tabassum
2012
8 4S p. P207
artikel
169 An LC-MS/MS-based method for quantification of beta-amyloid-1-38, beta-amyloid-1-40 and beta-amyloid-1-42 in the cerebrospinal fluid of Alzheimer's patients and healthy controls Pannee, Josef
2012
8 4S p. P240-P241
artikel
170 A nonhuman primate model of Alzheimer's disease with tangles and synapse loss triggered by Aß oligomers Forny-Germano, Leticia
2012
8 4S p. P203
artikel
171 A novel approach for lowering multiple targets in Alzheimer's disease Adwan, Lina
2012
8 4S p. P716
artikel
172 A novel BACE1-regulating protein with therapeutic potential Holsinger, R.M. Damian
2012
8 4S p. P475
artikel
173 A novel familial prion disease causing cognitive impairment, polyneuropathy and pan-autonomic involvement Matsuzono, Kousuke
2012
8 4S p. P623-P624
artikel
174 A novel LXR beta-selective partial agonist increases the ApoE-ABCA1 pathway and decreases hippocampal BETA-AMYLOID in cynomolgus monkeys without increasing liver triglycerides Bukhtiyarov, Yuri
2012
8 4S p. S752-S753
artikel
175 A novel mouse model of intraneuronal oligomers and congophilic amyloid angiopathy Kulic, Luka
2012
8 4S p. P627
artikel
176 Anteromedial temporal lobe diffusion tensor imaging and structural MRI changes in presymptomatic and symptomatic microtubule-associated protein tau (MAPT) mutation carriers Kantarci, Kejal
2012
8 4S p. P71
artikel
177 Anteromedial temporal lobe DTI and structural MRI changes in presymptomatic and symptomatic MAPT mutation carriers Kantarci, Kejal
2012
8 4S p. P170
artikel
178 Anti-amyloidogenic effects of isoflavones in vitro: Fluorescence spectroscopy demonstrating direct interactions between isoflavones and Aßs Hirohata, Mie
2012
8 4S p. P189
artikel
179 Anti-diabetic drugs protect the brain from defective insulin signaling caused by Alzheimer's toxic Aß oligomers Bomfim, Theresa
2012
8 4S p. P729
artikel
180 Antipsychotic use is not associated with an increased burden of cerebrovascular pathology at autopsy Singhal, Divvya
2012
8 4S p. P225-P226
artikel
181 Antisaccades in Alzheimer's disease using fMRI Wright, Sarah
2012
8 4S p. P51
artikel
182 Antisense targeting Aß precursor protein improves learning and memory in APPswe mice Farr, Susan
2012
8 4S p. P192
artikel
183 An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with early Alzheimer's disease Bose, Suchira
2012
8 4S p. P462-P463
artikel
184 An updated Aβ systems kinetic model for mouse, monkey and human Lu, Yasong
2012
8 4S p. P208
artikel
185 An update on an AIBL blood-based biomarker panel for the prediction of Aβ burden Faux, Noel
2012
8 4S p. P283
artikel
186 Anxiety state and memory abilities in rodent models of successful aging: The free-feeding Lou/C/Jall rat and calorie-restricted Sprague Dawley rat Menard, Caroline
2012
8 4S p. P206
artikel
187 Aβ oligomers in CSF are a biomarker for Alzheimer's disease Wang-Dietrich, Lei
2012
8 4S p. P121
artikel
188 Apathy and depression in subjective cognitive impairment (SCI) and mild cognitive impairment (MCI) Deutsch, Gayle
2012
8 4S p. P357
artikel
189 Apathy dimensions evolve differently with levels of dementia severity Agüera-Ortiz, Luis
2012
8 4S p. P622
artikel
190 Apathy in Dementia Methylphenidate Trial (ADMET): Preliminary efficacy report Mintzer, Jacobo
2012
8 4S p. P108
artikel
191 Apathy in dementia methylphenidate trial (ADMET): Recruiting for apathy in Alzheimer's disease Lanctot, Krista
2012
8 4S p. P588
artikel
192 AP-3 but not AP-1 mediates the direct and rapid trafficking of APP from Golgi to lysosomes Tam, Joshua
2012
8 4S p. P641
artikel
193 Aβ(pE3-42) potently stimulates CCL2 (MCP-1) secretion Eichentopf, Rico
2012
8 4S p. P300
artikel
194 A person-centered medical home for people living with dementia Lawhorne, Larry
2012
8 4S p. P431
artikel
195 A pharmacogenetic-supported clinical trial to delay onset of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) Roses, Allen D.
2012
8 4S p. S753
artikel
196 A phosphoinositol modulator, synaptojanin 1, regulates amyloid homeostasis Cai, Dongming
2012
8 4S p. P640-P641
artikel
197 A pilot survey to explore attitudes toward primary prevention, secondary prevention and Alzheimer's disease treatment clinical trials Dosanjh, Kulwant
2012
8 4S p. P586
artikel
198 A placebo-controlled crossover trial of the ±4β2 nicotinic acetylcholine receptor partial agonist varenicline in Alzheimer's disease Kim, Seong Yoon
2012
8 4S p. S768
artikel
199 APOE and cognitive dysfunction in Alzheimer's dementia and mild cognitive impairment Kamer, Adrian
2012
8 4S p. P537-P538
artikel
200 APOE-ε4 carriers show entorhinal and posterior cingulate cortical atrophy well before age 60 Chong, Catherine
2012
8 4S p. P618-P619
artikel
201 APOE-ε4 genotype affects brain function without apparent micro- and macrostructural changes in young adults: A multimodal fMRI, DTI and VBM study Prvulovic, David
2012
8 4S p. P619-P620
artikel
202 APOE-ε4 interaction with single-nucleotide polymorphisms and risk for Alzheimer's disease Kerr, Daniel
2012
8 4S p. P666
artikel
203 APOE-ε.4 status modulates the impact of cerebral white matter disease on cognition in Alzheimer's disease Ng, Adeline
2012
8 4S p. P487
artikel
204 Apolipoprotein E, dementia risk and cognitive development in a prospective population-based aging study in Germany Pfeiffer, Philipp
2012
8 4S p. P721
artikel
205 Apolipoprotein E-ε4 increases the risk for dementia in the ‘pure’ synucleopathies Tsuang, Debby
2012
8 4S p. P660
artikel
206 Apolipoprotein E polymorphisms do not affect the risk for dementia in elderly patients with bipolar disorder Nunes, Paula
2012
8 4S p. P661
artikel
207 Apolipoprotein 2: mRNA expression, protein level, and transcriptomal consequences in human postmortem cortical tissue Conejero-Goldberg, Concepcion
2012
8 4S p. P660
artikel
208 A potential ‘SYNTHETIC VESICLE’ as a therapeutic tool for Alzheimer's disease Gunawardena, Shermali
2012
8 4S p. P200
artikel
209 Apparent fibre density: A novel MRI approach that identifies specific white matter tracts affected in Alzheimer's disease and MCI Raffelt, David
2012
8 4S p. P690-P691
artikel
210 Apparent fibre density: A novel MRI approach that identifies specific white matter tracts affected in Alzheimer's disease and MCI Raffelt, David
2012
8 4S p. P61
artikel
211 APP associated with late-onset Alzheimer's disease in an autopsy-confirmed dataset Beecham, Gary
2012
8 4S p. P668
artikel
212 APP knock-in mouse: A novel and more relevant model mouse for Alzheimer's disease Saito, Takashi
2012
8 4S p. P203-P204
artikel
213 Application of a morphologically determined tomography dementia rating scale in the endovascular treatment of dyscirculatory angiopathy of the Alzheimer's type Maksimovich, Ivan
2012
8 4S p. P516-P517
artikel
214 APP-mediated regulation of neuronal cholesterol turnover and synaptic activity: A new therapeutic target for the treatment of Alzheimer's disease Pierrot, Nathalie
2012
8 4S p. S743-S744
artikel
215 A preliminary pharmacological study on anti-Alzheimer's disease drug candidate: Targeting on β-secretase Cheng, Xao-Rui
2012
8 4S p. P193
artikel
216 A quantitative assay selective for amyloid oligomer species differentiates cerebrospinal fluid from Alzheimer's disease and age-matched normal Wolfe, Abigail
2012
8 4S p. P278
artikel
217 A randomized double blind clinical trial comparing memantine and antipsychotics for the prophylaxis of behavioural and psychological symptoms in people with Alzheimer's disease (MAIN AD) Ballard, Clive
2012
8 4S p. S745
artikel
218 A randomized, double-blind, sponsor-unblinded, placebo- and positive-controlled study to evaluate the effects of single oral administrations of PF-04995274 on scopolamine-induced deficits in cognitive function in healthy adults Leurent, Claire
2012
8 4S p. P583
artikel
219 A randomized, multicenter, placebo controlled trial of memantine for behavioral variant FTD and semantic variant PPA Boxer, Adam
2012
8 4S p. P405
artikel
220 A rare mutation in the CTNND2 gene is associated with increased Aβ42 secretion Koutras, Carolina
2012
8 4S p. P469
artikel
221 Are cardiac effects of cholinesterase inhibitors important for the demented elderly? Isik, Ahmet Turan
2012
8 4S p. P710
artikel
222 Are depressive symptoms in mild cognitive impairment patients predictive for conversion to dementia? Dierckx, Eva
2012
8 4S p. P481
artikel
223 A regulatory immune response after DNA vaccination against Aß42 Lambracht-Washington, Doris
2012
8 4S p. P201
artikel
224 Are transgenic mice valid models of alzheimer's disease? Holtzman, Jordan
2012
8 4S p. P471-P472
artikel
225 A return to clinical skills in the early diagnosis of Alzheimer's disease Szoeke, Cassandra
2012
8 4S p. P491
artikel
226 A review of translated cognitive assessment tools to assess culturally and linguistically diverse (CALD) older people Logiudice, Dina
2012
8 4S p. P540
artikel
227 ARGO trial del Ser, Teodoro
2012
8 4S p. P455-P456
artikel
228 Aromatase variants modify risk for Alzheimer's disease in a multiethnic female cohort Janicki, Sarah
2012
8 4S p. P677-P678
artikel
229 Arterial stiffness and cognitive decline among black and white elders: Findings from the Health, Aging, and Body Composition Study Al Hazzouri, Adina Zeki
2012
8 4S p. P89
artikel
230 Arteriosclerosis and Alzheimer's disease: A case-control pathologic study Noble, James
2012
8 4S p. P298
artikel
231 Ascorbate deficiency interacts with icv-STZ model of Alzheimer's in monkeys Lee, Kyoung-Min
2012
8 4S p. P478
artikel
232 A specific microRNA (miR-339-5p) is reduced in Alzheimer's disease brain and able to lower BACE1 and BETA-AMYLOID peptide levels in human fetal brain cultures, suggesting a novel drug target for ALZHEIMER'S Lahiri, Debomoy
2012
8 4S p. S769
artikel
233 Assessing brain amyloid in nondemented adults with Down syndrome Handen, Benjamin
2012
8 4S p. S762-S763
artikel
234 Assessing cognition and function in Alzheimer's disease pharmacotherapy: A comparison of self-assessment by ChEI users and standardized test-scores Votova, Kristine
2012
8 4S p. P428
artikel
235 Assessing language function using the severe impairment battery (SIB) and mini-mental state examination (MMSE): Correlation analysis in patients with moderate-to-severe Alzheimer's disease Ferris, Steven
2012
8 4S p. P591
artikel
236 Assessing the ability of ADAS-Cog to capture all clinically meaningful changes in symptoms over time Mitnitski, Arnold
2012
8 4S p. P127
artikel
237 Assessing the usability of water taps by older adults with dementia Taati, Babak
2012
8 4S p. P230-P231
artikel
238 Assessment of disease progression in Alzheimer's transgenic mice by PET imaging with F-18 quinoline Kulkarni, Padmakar
2012
8 4S p. P155
artikel
239 Assessment of linguistic measures in neuropsychological testing of MCI: Assessing language components of the Addenbrooke's cognitive examination (ACE) Whitlock, Jordan
2012
8 4S p. P361-P362
artikel
240 Assessment of mitochondrial DNA from peripheral blood of Alzheimer's patients: Copy number, deletions and point mutations Roby, Rhonda
2012
8 4S p. P677
artikel
241 Assessment of product use by older adults with dementia: Automated video analysis Taati, Babak
2012
8 4S p. P444
artikel
242 Assessment of product use by older adults with dementia: Defining and analyzing usability Boger, Jennifer
2012
8 4S p. P383
artikel
243 Assessment of the drug-drug interaction between avagacestat (BMS-708163) and clopidogrel, carvedilol or diltiazem in healthy subjects Savant, Ishani
2012
8 4S p. P184
artikel
244 Assisting rural area providers in Illinois distinguish between Alzheimer's disease and Lewy body dementia Young, Charlene
2012
8 4S p. P125
artikel
245 Association between antioxidant level in blood and dementia: A population-based cross-sectional case-control study von Arnim, Christine
2012
8 4S p. P495-P496
artikel
246 Association between arteriosclerotic factors and risk and time of onset of Alzheimer's disease Matsumura, Miyuki
2012
8 4S p. P502
artikel
247 Association between brain amyloidosis, synaptic dysfunction and cognitive performance measured with ADAS-cog and MMSE scores in early MCI, late MCI and Alzheimer's disease Dauar, Marina
2012
8 4S p. P48-P49
artikel
248 Association between brain amyloidosis, synaptic dysfunction and cognitive performance measured with ADAS-cog and MMSE scores in EMCI, LMCI and Alzheimer's disease Dauar, Marina
2012
8 4S p. P524
artikel
249 Association between depressive symptoms, cognitive decline and white matter integrity in cognitively normal adults with a family history of Alzheimer's disease Lee, Grace
2012
8 4S p. P45
artikel
250 Association between depressive symptoms, cognitive decline, and white matter integrity in cognitively normal adults with a family history of Alzheimer's disease Lee, Grace
2012
8 4S p. P515-P516
artikel
251 Association between direct medical costs and reduced cognitive function within categories of normal cognition and mild cognitive impairment Leibson, Cynthia
2012
8 4S p. P134-P135
artikel
252 Association between driving performance and neuropsychological deficits in elderly people with mild cognitive impairment Jeong, Hyun-Ghang
2012
8 4S p. P359
artikel
253 Association between GWAS SNPs and CSF, MRI and cognition among subjects with MCI: Findings from the DESCRIPA study Lyzel, Elias-Sonnenschein
2012
8 4S p. P667
artikel
254 Association between promoter polymorphisms of the GRP78 gene and risk of Alzheimer's disease in a Chinese Han population Li, Keshen
2012
8 4S p. P671-P672
artikel
255 Association between variants in newly discovered Alzheimer's susceptibility genes and longitudinal cognitive performance in late middle-aged adults: The WRAP cohort Engelman, Corinne
2012
8 4S p. P666
artikel
256 Association of brain amyloidosis and metabolism with the Trail Making Test in MCI and Alzheimer's disease Mohades, Sara
2012
8 4S p. S774
artikel
257 Association of cognitive decline with cerebral metabolism and education in amnestic MCI: Implications for the cognitive reserve hypothesis Kato, Takashi
2012
8 4S p. P533
artikel
258 Association of CSF biomarkers to regional rates of FDG-PET metabolism in the Alzheimer's disease continuum Tosun, Duygu
2012
8 4S p. P331
artikel
259 Association of diabetes and prediabetes with cognitive impairment and depression among Chinese elderly people: The Confucius Hometown Aging Project Yan, Zhongrui
2012
8 4S p. P313
artikel
260 Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: Diverging behavior at three different brain regions Bittner, Daniel
2012
8 4S p. P330
artikel
261 Association of instrumental activities of daily living with MCI diagnosis in a large, older, community-based population Trittschuh, Emily
2012
8 4S p. P313
artikel
262 Association of maternal family history of dementia with Alzheimer's disease biomarkers Honea, Robyn
2012
8 4S p. P677
artikel
263 Associations of apathy with depression and NPS measured by standard scales in patients with moderate-to-advanced dementia Nicodemo, Izabel
2012
8 4S p. P545
artikel
264 Astrocyte-derived proteins in the cerebrospinal fluid as biomarkers for the pathobiological staging of Alzheimer's disease Schipke, Carola
2012
8 4S p. P116-P117
artikel
265 Astrocytes may drive a Beta-Amyloid contagion in human Alzheimer's disease brains Prà, Ilaria Dal
2012
8 4S p. S748
artikel
266 A study of adopting PEAP environmental modification methodology in Japan: A case of a nursing home for dementia in Taiwan Tzeng, Szu-Yu
2012
8 4S p. P561
artikel
267 A study of the life world of the spouses of people with Alzheimer's disease Bergman, Mette
2012
8 4S p. P562
artikel
268 A study to evaluate the pharmacokinetics and pharmacodynamics of single and multiple oral doses of the novel BACE inhibitor MK-8931 in Japanese subjects Min, K.
2012
8 4S p. P186
artikel
269 A survey on nutritional and other natural therapies for Alzheimer's disease Mishra, Vikash
2012
8 4S p. P404
artikel
270 Asymptomatic stroke can aggravate the severity of apathy in patients with Alzheimer's disease Moon, Yeonsil
2012
8 4S p. P557
artikel
271 A systematic literature review of the trail-making test and its effectiveness in identifying cognitively impaired drivers Shergill, Simran
2012
8 4S p. P558
artikel
272 Atherosclerotic disease at different locations and progression of brain atrophy and white matter lesions after 4 years of follow-up: The SMART-MR study van der Veen, Erika
2012
8 4S p. P732
artikel
273 Atorvastatin and pitavastatin reduce senile plaques and inflammatory responses in model mice with Alzheimer's disease Kurata, Tomoko
2012
8 4S p. P193
artikel
274 ATP-binding cassette transporter A7 (ABCA7) effects on amyloid processing and relevance to Alzheimer's disease Satoh, Kanayo
2012
8 4S p. P473
artikel
275 ATP5H/KCTD2 locus and Alzheimer's disease: An etiological link between key brain functions and dementia Rovira, Mercè Boada
2012
8 4S p. P721
artikel
276 Attenuation of beta-amyloid-induced activation of astrocytes by curcumin: Role of protein SUMOylation Hoppe, Juliana Bender
2012
8 4S p. P654
artikel
277 Attitudes of the German general population toward early diagnosis of dementia Luck, Tobias
2012
8 4S p. P565
artikel
278 Attributable risk of mortality from incident Alzheimer's disease James, Bryan
2012
8 4S p. P319
artikel
279 A two-study comparison of clinical and MRI markers of transition from mild cognitive impairment to Alzheimer's disease Devanand, Davangere
2012
8 4S p. P432-P433
artikel
280 Auditory spatial processing in Alzheimer's disease Crutch, Sebastian
2012
8 4S p. P742
artikel
281 Aβ uptake by non-plaque associated microglia Hawkes, Cheryl
2012
8 4S p. P703
artikel
282 Aurin tricarboxylic acid may help Alzheimer's disease and other conditions by blocking the MAC of complement Lee, Moonhee
2012
8 4S p. P418
artikel
283 Autoimmunization leads to elevated anti-beta-amyloid antibodies in Down syndrome (DS) Coppus, Antonia
2012
8 4S p. P174
artikel
284 Automated and robust algorithm to measure changes in medial temporal lobe volume in early Alzheimer's disease Kazemifar, Samaneh
2012
8 4S p. P29-P30
artikel
285 Automated hippocampal shape analysis in normal aging, mild cognitive impairment and Alzheimer's disease Rhee, Hak Young
2012
8 4S p. P691
artikel
286 Automated hippocampal subfields segmentation in amnestic mild cognitive impairment Lee, Chung Tai
2012
8 4S p. P532
artikel
287 Automated index of semantic verbal fluency in mild cognitive impairment and Alzheimer's disease Pakhomov, Serguei
2012
8 4S p. P555
artikel
288 Automated measurement of clustering versus traditional semantic verbal fluency: Differential prediction of rate of cognitive decline Hemmy, Laura
2012
8 4S p. P547
artikel
289 Automated quantitative analysis of clustering and response timing on the semantic verbal fluency test Pakhomov, Serguei
2012
8 4S p. P547
artikel
290 Automated segmentation of hippocampal subfields in drug-naive patients with Alzheimer's disease Won, Wangyoun
2012
8 4S p. P534
artikel
291 Automated semantic indices are related to functional brain networks in MCI and Alzheimer's disease Hemmy, Laura
2012
8 4S p. P548
artikel
292 Automatic detection of Alzheimer's disease in multicenter diffusion tensor imaging data Dyrba, Martin
2012
8 4S p. P24-P25
artikel
293 Automatic detection of Alzheimer's disease in multicenter DTI data Dyrba, Martin
2012
8 4S p. P341-P342
artikel
294 Autophagic aggregates resembling granulovacuolar degeneration in a Drosophila model of tauopathy Bakhoum, Mathieu
2012
8 4S p. P294
artikel
295 Autophagy and apoptotic genes implicated in Alzheimer's disease are modulated following infection of neuronal cells with Chlamydia pneumoniae Kohler, Ian
2012
8 4S p. P293-P294
artikel
296 Autophagy deficiency increases beta-amyloid pathology and memory impairment in APP transgenic mice Nilsson, Per
2012
8 4S p. P642
artikel
297 Avagacestat (BMS-708163) exposures and study discontinuations in patients with mild-to-moderate Alzheimer's disease AbuTarif, Malaz
2012
8 4S p. P601
artikel
298 Avagacestat for predementia Alzheimer's disease: Methods and baseline results Coric, Vlad
2012
8 4S p. P408-P409
artikel
299 A voxel-based morphometry study of volumetric MRI in familial Alzheimer's disease Cash, David
2012
8 4S p. P17-P18
artikel
300 A voxel-based morphometry study of volumetric MRI in familial Alzheimer's disease Cash, David
2012
8 4S p. P247-P248
artikel
301 A 12-week, double-blind, placebo-controlled, dose-range finding study of CHF5074 in patients with mild cognitive impairment Ross, Joel
2012
8 4S p. P200-P201
artikel
302 A yeast model for studying intracellular clearance of beta-amyloid 42 Bharadwaj, Prashant
2012
8 4S p. P642
artikel
303 BACE inhibitor LY2886721 safety and central and peripheral PK and PD in healthy subjects (HSs) Martenyi, Ferenc
2012
8 4S p. P583-P584
artikel
304 Barriers to the cognitive assessment of dementia in India Kuriakose, Jacob
2012
8 4S p. P227
artikel
305 Baseline clinical scores and volumetric MRI parameters across subjects randomized in mild-to-moderate (BMS CN156-013) and predementia (BMS CN156-018) Alzheimer's disease clinical trials of avagacestat Bracoud, Luc
2012
8 4S p. P73-P74
artikel
306 Baseline clinical scores and volumetric MRI parameters across subjects randomized in mild-to-moderate (BMS CN156-013) and predementia (BMS CN156-018) Alzheimer's disease clinical trials of avagacestat Bracoud, Luc
2012
8 4S p. P409
artikel
307 Baseline CSF BETA-AMYLOID 42 correlates with ApoE genotype and baseline cognitive status in a phase II avagacestat predementia Alzheimer's disease study Soares, Holly
2012
8 4S p. S782
artikel
308 Behavioral alternatives to anti-psychotic prescribing for people with dementia in residential care settings Ballard, Clive
2012
8 4S p. P230
artikel
309 Behavioral performance as a predictor of cognitive decline: Detecting the transition from healthy aging to mild cognitive impairment Zola, Stuart
2012
8 4S p. S791
artikel
310 Behavioral reserve in mild cognitive impairment and mild Alzheimer's disease Apostolova, Liana
2012
8 4S p. P323
artikel
311 Behavioural and cerebral metabolism assessment of TASTPM transgenic mice using a ‘touchscreen’-based cognitive task Gartlon, Jane
2012
8 4S p. P204
artikel
312 Beneficial catalytic autoimmunity to beta-amyloid peptide Nishiyama, Yasuhiro
2012
8 4S p. P706
artikel
313 Beneficial effects of IVIg in the triple transgenic mouse model of Alzheimer's disease St-Amour, Isabelle
2012
8 4S p. P576
artikel
314 Benefits of memantine in the treatment of Alzheimer's disease in a naturalistic setting Riepe, Matthias W.
2012
8 4S p. P588-P589
artikel
315 Beta-amyloid aggregation human systems pharmacology modeling: Development and application to pharmacological targets in Alzheimer's disease Nicholas, Timothy
2012
8 4S p. P192-P193
artikel
316 Beta-amyloid burden alters default mode and salience network connectivity associated with impaired cognition in healthy aging Devous, Michael
2012
8 4S p. P67
artikel
317 Beta-amyloid burden alters default mode and salience network connectivity associated with impaired cognition in healthy aging Devous, Michael D.
2012
8 4S p. P5-P6
artikel
318 Beta-amyloid deposition in normal elderly is related to longitudinal but not cross-sectional cognitive decline Wirth, Miranka
2012
8 4S p. P102
artikel
319 Beta-amyloid-17 is a major beta-amyloid fragment isoform in cerebrospinal fluid and blood that shows diagnostic value Pérez, Virginia
2012
8 4S p. P240
artikel
320 Beta-amyloid neurotoxicity and neuroprotective role of 17β estradiol in aging rat brain synaptosomes Kumar, Pardeep
2012
8 4S p. P572
artikel
321 Beta-amyloid oligomer detection in cerebrospinal fluid and brain tissue Bruggink, Kim
2012
8 4S p. P239-P240
artikel
322 BETA-AMYLOID oligomerization in Alzheimer's DISEASE DEMENTIA versus high pathology controls Brody, David
2012
8 4S p. S752
artikel
323 Beta-amyloid peptide 1-42 binds to N-terminal fragment of cytochrome C oxidase subunit 1 (COX1) Hernández, Luis
2012
8 4S p. P305-P306
artikel
324 Beta-amyloid peptides undergo activity-dependent secretion with neurotransmitters Hook, Vivian
2012
8 4S p. P241
artikel
325 Beta-amyloid production from reactive astrocytes induced by endogenous neurotoxin quinolinic acid: A new aspect of Alzheimer's disease Okuno, Alato
2012
8 4S p. P656
artikel
326 Beta-amyloid reduces the expression of antioxidant repair genes Duran, Jorge
2012
8 4S p. P670
artikel
327 Beta-amyloid resistance and the Warburg effect: New insight into Alzheimer's disease from old metabolic pathways Newington, Jordan
2012
8 4S p. P306
artikel
328 Beta-amyloid-specific CD4+ T cell responses change with age and Alzheimer's disease Ethell, Doug
2012
8 4S p. P239
artikel
329 17-beta-estradiol: A potential therapeutic drug for Alzheimer's disease Kumar, Pardeep
2012
8 4S p. P399
artikel
330 Biochemical consequences of traumatic brain injury in dementia pugilistica Kokjohn, Tyler
2012
8 4S p. P178
artikel
331 Biochemical correlates of clinical symptoms in dementia with Lewy bodies and Parkinson's disease dementia Whitfield, David
2012
8 4S p. P643
artikel
332 Biological knowledge-driven approach to gene-gene interaction analysis in the Alzheimer's Disease Genetics Consortium Thornton-Wells, Tricia
2012
8 4S p. P681-P682
artikel
333 Biological standards to control variability in cerebrospinal fluid beta-amyloid readings Edland, Steven
2012
8 4S p. P217
artikel
334 Biomarker and long-term effects of cholinesterase inhibitors in Alzheimer's disease and MCI Davis, Bonnie
2012
8 4S p. P116
artikel
335 Biomarker correlates in the ADNI Alzheimer's dementia population suggesting dementia unlikely due to Alzheimer's disease Lowe, Val
2012
8 4S p. P76-P77
artikel
336 Biomarker correlates in the ADNI Alzheimer's disease dementia population suggesting dementia unlikely due to Alzheimer's Lowe, Val
2012
8 4S p. P289
artikel
337 Biomarkers for Alzheimer's disease: The truth is in the details Alzate, Oscar
2012
8 4S p. P268
artikel
338 Biomarkers of depressive symptoms in Alzheimer's disease: Gender differences Hall, James
2012
8 4S p. P117
artikel
339 Biomarkers of fatty acid oxidation in a clinical trial of DHA for Alzheimer's disease Quinn, Joseph
2012
8 4S p. P585
artikel
340 Biomarkers of metabolic function for early detection of women at risk for Alzheimer's disease Rettberg, Jamaica
2012
8 4S p. P281-P282
artikel
341 Bionetwork-based study of combinational therapeutic targets for Alzheimer's disease: A practice for network pharmacology Zhou, Wenxia
2012
8 4S p. P581
artikel
342 Biophysical studies on the interactions of BETA-AMYLOID and pseudopeptidic inhibitors of BETA-AMYLOID oligomerization: Molecular dynamics simulations Petoyan, Anahit
2012
8 4S p. S778
artikel
343 Black-and-white trail-making test Kim, JungEun
2012
8 4S p. P362
artikel
344 Blood assay to detect oligomeric beta-amyloid with high sensitivity and specificity An, Seong
2012
8 4S p. S747
artikel
345 Blood monocyte levels of new mid-domain BETA-AMYLOID-degradation-based peptide correlates strongly with CSF biomarkers Møllergård, Hanne Mali
2012
8 4S p. S774-S775
artikel
346 Blood pressure and progression of brain atrophy—lower is not always better: The SMART-MR study Jochemsen, Hadassa
2012
8 4S p. P89
artikel
347 Blood pressure, memory, and executive function changes in late-life Oveisgharan, Shahram
2012
8 4S p. P88
artikel
348 Body mass index and dementia in the oldest-old: The Monzino 80-Plus Study Lucca, Ugo
2012
8 4S p. P326
artikel
349 Body mass index in midlife is not associated with dementia and brain damage Davis, Benjamin
2012
8 4S p. P254
artikel
350 Brain amyloid deposition and metabolism in early and late mild cognitive impairment Rowley, Jared
2012
8 4S p. P12-P13
artikel
351 Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study Kinnunen, Kirsi
2012
8 4S p. P72-P73
artikel
352 Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study Kinnunen, Kirsi
2012
8 4S p. P112-P113
artikel
353 Brain atrophy in Alzheimer's disease: Involvement of vitamin D insufficiency Annweiler, Cedric
2012
8 4S p. P319
artikel
354 Brain beta-amyloid deposition and metabolism in early and late mild cognitive impairment Wu, Liyong
2012
8 4S p. P485-P486
artikel
355 Brain-derived and synthetic Aβ aggregates are prions Stoehr, Jan
2012
8 4S p. P434
artikel
356 Brain morphological changes correlate with subjective cognitive symptoms in 85-year-olds Sacuiu, Simona
2012
8 4S p. P150
artikel
357 Brain regional distribution of apolipoprotein E and beta-amyloid peptides in cognitively normal persons Shinohara, Mitsuru
2012
8 4S p. P660-P661
artikel
358 Brain regions associated with baseline cognitive function and subsequent decline in normal aging and mild cognitive impairment as measured with MRI and FDG-PET Bauer, Corinna
2012
8 4S p. P510
artikel
359 Brain regions associated with baseline cognitive function and subsequent decline in normal aging and mild cognitive impairment as measured with MRI and FDG-PET Bauer, Corinna
2012
8 4S p. P43
artikel
360 Brains for Dementia Research: Providing human tissue for dementia research to promote understanding of pathogenesis and aid drug discovery Hayes, Gillian
2012
8 4S p. P298
artikel
361 Brain tocopherol levels are inversely associated with Alzheimer's disease neuropathology in humans Morris, Martha Clare
2012
8 4S p. P450
artikel
362 BRICHOS domains efficiently prevent fibrillation of beta-amyloid peptide Johansson, Jan
2012
8 4S p. P653-P654
artikel
363 Bridging integrator 1 (BIN1) as a new partner of Tau? Chapuis, Julien
2012
8 4S p. P459-P460
artikel
364 BRI2 in Alzheimer's disease Del Campo Milan, Marta
2012
8 4S p. P278
artikel
365 Calcineurin disrupts fast axonal transport independently of tau in beta-amyloid oligomer-treated hippocampal neurons Gan, Kathlyn
2012
8 4S p. S759-S760
artikel
366 Calcineurin inhibition alters APP metabolism in vitro and in vivo Saunders, Aleister
2012
8 4S p. P209
artikel
367 CALHM2 interacts with CALHM1 and CALHM3 and inhibits Ca2+ channel activity Ha, Sungji
2012
8 4S p. S762
artikel
368 Calycopterin induces mitochondrial biogenesis and autophagy in PC12 neuron-like cells exposed to H2O2 Sarvestani, Nazanin Namazi
2012
8 4S p. P308
artikel
369 Can ballroom dancing make you smarter? An investigation on its relationship with hippocampal volume and memory performance in older adults Carcel, Cheryl
2012
8 4S p. P142
artikel
370 Candidate gene study in the endosome-to-Golgi retrieval pathway reveals association of retromer genes with Alzheimer's disease Vardarajan, Badri Narayan
2012
8 4S p. P664
artikel
371 Candidate serum IGG biomarkers of Alzheimer's disease Kodadek, Thomas
2012
8 4S p. P79
artikel
372 Can memory profiling predict progression to Alzheimer's disease in amnestic mild cognitive impairment? Jones, Andrew
2012
8 4S p. P358
artikel
373 Cannabinoid effects on nonassociative learning in mice Avdesh, Avdesh
2012
8 4S p. P195-P196
artikel
374 Cannabinoid ligands directly modify beta-amyloid fibril formation and are variably neuroprotective in vitro Smid, Scott
2012
8 4S p. P657
artikel
375 Can Rowland Universal Dementia Assessment Scale (RUDAS) be used in place of mini-mental state examination (MMSE) for dementia screening in Thai geriatrics? Limpawattana, Panita
2012
8 4S p. P128-P129
artikel
376 Can sitagliptin, a GLP-1 inhibitor, improve cognitive function in elderly diabetic patients with Alzheimer's disease? Isik, Ahmet Turan
2012
8 4S p. P710
artikel
377 Can the performance of the FSL/Siena whole brain atrophy measure be improved at 3T and 1.5T on ADNI back-to-back MPRAGES by using a non-default settings? Cover, Keith
2012
8 4S p. P338
artikel
378 Can the revised Hasegawa's dementia scale replace the MMSE as a screening test for dementia? Choi, Seungho
2012
8 4S p. P556
artikel
379 Can we further divide amnestic mild cognitive impairment based on the pattern of memory deficit? Jeong, Eun Hye
2012
8 4S p. P513-P514
artikel
380 Capacity building for dealing with dementia in developing countries: Lessons from the Maracaibo Aging Study Quintero-Osorio, Marialcira
2012
8 4S p. P430
artikel
381 Capitalizing on complementary FDG PET and florbetapir PET data sets to distinguish between early and late mild cognitive impairment using multi-modal partial least squares Protas, Hillary
2012
8 4S p. P334
artikel
382 Capitalizing on complementary FDG-PET and florbetapir-PET data sets to distinguish between early and late mild cognitive impairment using multimodal partial least squares Protas, Hillary
2012
8 4S p. P20
artikel
383 Cardiovascular response during maximal treadmill exercise in patients with mild cognitive impairment Tseng, Benjamin
2012
8 4S p. P89-P90
artikel
384 Cardiovascular risk factors and frontotemporal dementia (FTD) Golimstok, Angel
2012
8 4S p. S760
artikel
385 CARE: Caregiver Latin American Study Gomes, Marcelo
2012
8 4S p. S760
artikel
386 Caregiver burden as illness progresses in Alzheimer's disease (AD): Association with patient dependence on others and other factors—Results from the Dependence in Alzheimer's Disease in England (DADE) study Lacey, Loretto
2012
8 4S p. P248-P249
artikel
387 Caregiver coping strategies predict neuropsychiatric symptoms in dementia: The Cache County Dementia Progression Study Tschanz, JoAnn
2012
8 4S p. P126
artikel
388 Caregivers' burden in north east of Italy: Evidence from the Treviso dementia (Tredem) study Gallucci, Maurizio
2012
8 4S p. P374
artikel
389 Caregiver sleep, depression and stress: Impact on immune, endocrine and inflammatory biomarkers Rowe, Meredeth
2012
8 4S p. P380-P381
artikel
390 Caregivers' perspectives of care problems: An exploratory study in Taiwan Chiu, Ying-Nien
2012
8 4S p. P383
artikel
391 Caregiving across the United States: BRFSS data reveal the impact of Alzheimer's disease and dementia Bouldin, Erin
2012
8 4S p. P599
artikel
392 Caring for the caregiver: Benefits from a different dosage form Articus, Konstantin
2012
8 4S p. P396
artikel
393 δ-Catenin is genetically and biologically associated with cortical cataract and future Alzheimer's-related structural and functional brain changes Jun, Gyungah
2012
8 4S p. P452
artikel
394 Cathepsin B gene deletion and cysteine protease inhibition are effective in a traumatic brain injury model Kindy, Mark
2012
8 4S p. P577
artikel
395 Cathepsin B gene deletion or inhibition improves memory deficits in a mouse model of Alzheimer's disease expressing APP with the wild-type beta-secretase site Hook, Greg
2012
8 4S p. P386-P387
artikel
396 Caucasians and Africans have different susceptibility to neuritic plaques: A population-based clinicopathological study using genetic ancestry-informative markers Grinberg, Lea
2012
8 4S p. P446-P447
artikel
397 C. elegans model of patterned neurodegeneration induced by APP for high-throughput drug screening Crisp, Ashley
2012
8 4S p. P307
artikel
398 Central BACE1 inhibition by LY2886721 produces opposing effects on APP processing as reflected by cerebrospinal fluid sAPPalpha and sAPPbeta Willis, Brian
2012
8 4S p. P582
artikel
399 Central BACE1 inhibition by LY2886721 produces opposing effects on APP processing as reflected by cerebrospinal fluid sAPP-alpha and sAPP-beta Willis, Brian
2012
8 4S p. P95
artikel
400 Central nervous system activity of thioctic acid enantiomers in an animal model of cerebrovascular disease Nwankwo, Innocent
2012
8 4S p. P179
artikel
401 Cerebral atherosclerosis is associated with cystic and microinfarcts, but not Alzheimer's pathology Zheng, Ling
2012
8 4S p. P732-P734
artikel
402 Cerebral blood flow changes in early Alzheimer's disease: A high-field arterial spin labeling perfusion MRI study Song, Xiaowei
2012
8 4S p. P350
artikel
403 Cerebral blood flow changes in early Alzheimer's disease: A high-field arterial spin labeling perfusion MRI study Song, Xiaowei
2012
8 4S p. P35
artikel
404 Cerebral blood flow measured with arterial spin–labeled perfusion MRI at 3T and structural brain changes in Alzheimer's disease Prins, Niels
2012
8 4S p. P65
artikel
405 Cerebral blood flow, measured with ASL perfusion MRI at 3T, and structural brain changes in Alzheimer's disease Prins, Niels
2012
8 4S p. P737
artikel
406 Cerebral encephalopathy with cerebral amyloid angiopathy and numerous amyloid plaques presenting aberrant low levels of CSF Aβ 40/1-42 Hirayanagi, Kimitoshi
2012
8 4S p. P127-P128
artikel
407 Cerebral hypoperfusion in young transgenic APP mice predicts spatial distribution of amyloid deposition Grand'Maison, Marilyn
2012
8 4S p. P12
artikel
408 Cerebral ischemia-induced elevation of O-GlcNAcylation causes AKT inhibition and apoptosis Shi, Jianhua
2012
8 4S p. P651
artikel
409 Cerebral microbleeds and cognitive impairment in community-dwelling elderly from Singapore Ikram, Mohammad Kamran
2012
8 4S p. P618
artikel
410 Cerebral microbleeds are unrelated to cognitive functioning in patients with MCI and Alzheimer's disease Heringa, Sophie
2012
8 4S p. P53
artikel
411 Cerebral microbleeds are unrelated to cognitive functioning in patients with MCI and Alzheimer's disease Heringa, Sophie
2012
8 4S p. P532
artikel
412 Cerebral structural changes in different transgenic models of Alzheimer's disease: An MRI study Micotti, Edoardo
2012
8 4S p. P152
artikel
413 Cerebral white matter disease adversely affects cued recall in Alzheimer's disease Lin, Xuling
2012
8 4S p. P133
artikel
414 Cerebrospinal fluid biochemical biomarkers of depressive symptoms in older adults Leung, Yuk Yee
2012
8 4S p. P280
artikel
415 Cerebrospinal fluid biomarker profile in late-life depression and association with cognitive impairment Luborzewski, Alexander
2012
8 4S p. P408
artikel
416 Cerebrospinal fluid biomarkers for Alzheimer's disease and specific cognitive decline in subjects with mild cognitive impairment Ramakers, Inez
2012
8 4S p. P634
artikel
417 Cerebrospinal fluid biomarkers for Alzheimer's disease are associated with neuropathology in cortical brain biopsy Seppälä, Toni
2012
8 4S p. P83-P84
artikel
418 Cerebrospinal fluid biomarker standardization efforts Mattsson, Niklas
2012
8 4S p. P606
artikel
419 Cerebrospinal fluid (CSF) biomarkers in Alzheimer's disease (AD), mild cognitively impaired (MCI) and age-matched healthy controls (HC) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort Siuciak, Judith
2012
8 4S p. P216-P217
artikel
420 Cerebrospinal fluid (CSF) vs. plasma-based biomarkers in Alzheimer's disease (AD), mild cognitive impaired (MCI) and age-matched healthy controls (HC) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort Potter, William
2012
8 4S p. P217
artikel
421 Cerebrospinal fluid L-arginine and symmetrical dimethylarginine are associated with increased soluble amyloid precursor protein beta production in Alzheimer's disease Popp, Julius
2012
8 4S p. P654
artikel
422 Cerebrospinal fluid markers for predicting Alzheimer's-type dementia in subjects with amnestic versus non-amnestic mild cognitive impairment Vos, Stephanie
2012
8 4S p. P262-P263
artikel
423 Cerebrospinal fluid profiles of Aβ-related biomarkers in Alzheimer's disease Rosén, Christoffer
2012
8 4S p. P111-P112
artikel
424 Cerebrovascular lesions and vascular risk factors in patients with Alzheimer's disease Nagata, Ken
2012
8 4S p. P522
artikel
425 Challenges for the detection of dementia in culturally, racially and ethnically diverse populations Manly, Jennifer
2012
8 4S p. P234-P235
artikel
426 Change in inflammatory markers and cognitive status in oldest-old women Metti, Andrea
2012
8 4S p. P731
artikel
427 Changes in core biomarkers in cerebrospinal fluid and cognitive ability in patients with Alzheimer's disease: A two-year longitudinal study Sando, Sigrid
2012
8 4S p. P485
artikel
428 Changes in fMRI resting state functional connectivity in rats after acute and repeat dosing with Pioglitazone Asin, Karen
2012
8 4S p. S748-S749
artikel
429 Changes in gastric myoelectrical activity in response to nicotine in a mouse model of Alzheimer's disease Wang, Eileen
2012
8 4S p. S787-S788
artikel
430 Changes in sleep/wake parameters in male PD-APP transgenic mice Shanks, Elaine
2012
8 4S p. P201-P202
artikel
431 Changes in the Veterans Affairs Saint Louis University Mental Status (SLUMS) Exam scores over 7.5 years' follow-up and related outcomes: The influence of reversible cognitive impairment and correction of sensory loss Cruz-Oliver, Dulce
2012
8 4S p. P481
artikel
432 Changes of carotid duplex sonographic findings before and after carotid artery stenting in a post-stroke dementia Lee, Jun Hong
2012
8 4S p. P167-P168
artikel
433 Characterisation of tau and phospho-tau populations within CSF: The relevance to Alzheimer's biomarker development Schofield, Emma
2012
8 4S p. P114
artikel
434 Characterization of APPsi transgenic rats for cognitive deficits and brain pathology Obermüller, Beate
2012
8 4S p. P210
artikel
435 Characterization of brain plasticity in Alzheimer's disease patients and healthy subjects Brem, Anna-Katharine
2012
8 4S p. P274-P275
artikel
436 Characterization of frontotemporal dementia +/- amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 Boeve, Bradley
2012
8 4S p. P94
artikel
437 Characterization of GSAP's role in modulating APP processing Gonzalez-DeWhitt, Patricia
2012
8 4S p. P225
artikel
438 Characterization of SUVN-D1104010: A potent, selective and orally active 5-HT4 receptor partial agonist Nirogi, Ramakrishna
2012
8 4S p. P400
artikel
439 Characterizing brain amyloid changes using PiB-PET: Progression, clinical correlates, PiB status and optimized sampling Mosconi, Lisa
2012
8 4S p. P339-P340
artikel
440 Choice of endpoints, meta-analyses and clinical judgment for treatments of Alzheimer's disease Riepe, Matthias W.
2012
8 4S p. P455
artikel
441 Choice of threshold hippocampal volume as a selection criterion in prodromal Alzheimer's disease Novak, Gerald
2012
8 4S p. P491
artikel
442 Cholesterol ester transfer protein–deficient polymorphisms alter cerebrospinal fluid biomarkers and reduce Alzheimer's disease–related cognitive impairment in apolipoprotein E-ε4 carriers Hayashi, Ikuo
2012
8 4S p. P659-P660
artikel
443 Cholesterol oxidation products induce spots of beta-amyloid aggregation on neuronal cells and may potentiate the peptide neurotoxic effects: A molecular link between hypercholesterolemia and Alzheimer's disease Poli, Giuseppe
2012
8 4S p. P477
artikel
444 Cholinesterase inhibitor (ChEI) treatment benefits in mild compared to moderate Alzheimer's disease Wakefield, Sarah
2012
8 4S p. P579
artikel
445 Cholinesterase inhibitors and memantine use in the National Alzheimer's Coordinating Center's Uniform Data Set: A longitudinal assessment of real-world medication use in dementia Meranus, Dana
2012
8 4S p. P711
artikel
446 Cholinesterase inhibitors increase iPLA2 activity in platelets of patients with Alzheimer's disease Talib, Leda
2012
8 4S p. P113
artikel
447 Chracterization of brain APL2beta, an BETA-AMYLOID-like peptide produced from APLP2 Okochi, Masayasu
2012
8 4S p. S777
artikel
448 Chromosome 21-encoded miRNA-155 upregulation and complement factor H (CFH) deficits in Down syndrome (DS) and Alzheimer's disease (AD) Li, Y.Y.
2012
8 4S p. P303
artikel
449 Chronic BACE inhibition dramatically slows the rate of Aß accumulation and the development of amyloid plaques in young TgCRND8 mice Hyde, Lynn
2012
8 4S p. P188
artikel
450 Chronic BACE inhibition halts further age-related increases in brain Aß and amyloid plaques in aged TgCRND8 mice with established plaques Hyde, Lynn
2012
8 4S p. P188
artikel
451 Chronic inhibition of the MEK/ERK pathway fails to delay disease progression in a transgenic animal model of tauopathy Bose, Suchira
2012
8 4S p. P463
artikel
452 Chronic multimorbidity affects hippocampal volume in nondemented older individuals Kalpouzos, Grégoria
2012
8 4S p. P440
artikel
453 Chronic subcutaneous application of sodium azide to muscarinic M2 receptors: Knockout mice and animal modeling of Alzheimer's disease Ripova, Daniela
2012
8 4S p. P304
artikel
454 Chronic traumatic encephalopathy (CTE) in blast-exposed U.S. military veterans and a new blast neurotrauma mouse model Goldstein, Lee
2012
8 4S p. P212-P213
artikel
455 Cilostazol attenuates cognitive dysfunction by enhancing synaptogenesis in a rat model of chronic cerebral hypoperfusion with type II diabetes Kwon, Kyoung Ja
2012
8 4S p. P213
artikel
456 Circadian patterns of beta-amyloid in human cerebrospinal fluid and plasma Huang, Yafei
2012
8 4S p. P234
artikel
457 Circulating Aβ40 influences plasma BDNF levels and white matter integrity Pomara, Nunzio
2012
8 4S p. P267
artikel
458 Circulo de Cuidado: A randomized controlled trial of a behavioral group intervention for Latino Alzheimer's caregivers Gonyea, Judith
2012
8 4S p. P250
artikel
459 Classification of Alzheimer's disease using multiplex plasma-based biomarkers Hye, Abdul
2012
8 4S p. P407
artikel
460 Classification of Alzheimer's subject based on PiB-MR manifold learning Bourgeat, Pierrick
2012
8 4S p. P28-P29
artikel
461 Classification of Alzheimer's subjects based on PiB-MR manifold learning Bourgeat, Pierrick
2012
8 4S p. P344
artikel
462 Classification of MCI and Alzheimer's disease from CSF biomarkers: An ADNI study of Aß, tau and P-tau versus 83 proteomic analytes Li, Taiyong
2012
8 4S p. P609-P610
artikel
463 Cleavage of TDP-43 by caspase-3 is critical in apoptotic cell death Liu, Rui
2012
8 4S p. P308-P309
artikel
464 Clinical applications for the Ntelligent geriatric serious games for mild cognitive impairment Lee, Chan-Nyoung
2012
8 4S p. P480
artikel
465 Clinical, behavioral and treatment differences in nursing home residents with dementia, with and without PBA symptomatology Zarowitz, Barbara
2012
8 4S p. S776
artikel
466 Clinical characteristics of Alzheimer's disease at initial visit to Belgrade Memory Centre: Serbian report Stojkovic, Tanja
2012
8 4S p. P132
artikel
467 Clinical features of Pittsburgh compound-B–negative dementia Takeuchi, Jun
2012
8 4S p. P161
artikel
468 Clinical gait assessment in the old-old population in a community: The Kurihara Project Tanaka, Naofumi
2012
8 4S p. P99-P100
artikel
469 Clinical impacts of small vessel disease and amyloid burden Park, Jae Hyun
2012
8 4S p. P614-P616
artikel
470 Clinical outcomes for stages of NIA-AA preclinical Alzheimer's disease Knopman, David
2012
8 4S p. P102
artikel
471 Clinical, pathological and genetic aspects of C9ORF72 mutations Mackenzie, Ian
2012
8 4S p. P729
artikel
472 Clinical pathological correlations of dementia in the oldest-old: The effect of multiple pathologies Kawas, Claudia
2012
8 4S p. P447
artikel
473 Clinical spectrum of familial Alzheimer's disease in 100 cases Ryan, Natalie
2012
8 4S p. P262
artikel
474 Clinical use of imaging in light of new diagnostic criteria of Alzheimer's DeCarli, Charles
2012
8 4S p. P1
artikel
475 Clinicopathological correlations of the frontal lobe syndrome: Results of a large brain bank study Bosman, Sjanne
2012
8 4S p. P623
artikel
476 CLU and CR1 poymorphisms and ALZHEIMER'S disease in a Brazilian population Lanna, Flávia
2012
8 4S p. S769-S770
artikel
477 Coated-platelets: A biomarker for rapid progression of dementia in Alzheimer's disease Prodan, Calin
2012
8 4S p. P207
artikel
478 Coenzyme Q10 restores beta-amyloid–inhibited proliferation of neural stem cells by activating the PI3K Pathway Hojin, Choi
2012
8 4S p. P476-P477
artikel
479 Coevolution of brain structures in mild cognitive impairment Carmichael, Owen
2012
8 4S p. P26-P27
artikel
480 Coevolution of brain structures in mild cognitive impairment Carmichael, Owen
2012
8 4S p. P343-P344
artikel
481 Coffee consumption and the risk of dementia in the oldest-old: The Monzino 80-plus study Lucca, Ugo
2012
8 4S p. P629-P630
artikel
482 Cognition and cerebral neurovascular coupling in the elderly with metabolic syndrome Shigaeff, Nadia
2012
8 4S p. P492
artikel
483 Cognition and gait reveal distinct patterns of association in an aging population Ikram, Mohammad
2012
8 4S p. P99
artikel
484 Cognition, hippocampal volume and fibrillar Aβ burden as predictors of cognitive decline: Three-year follow-up results from AIBL Rowe, Christopher
2012
8 4S p. P433
artikel
485 Cognitive activity predicted better cognitive function in community-dwelling elderly Chinese over a five-year period Fung, Ada
2012
8 4S p. P139-P140
artikel
486 Cognitive and affective changes in mild-to-moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors enrolled in the EVOLUTION study: The effect of different inhibitor/formulation Spalletta, Gianfranco
2012
8 4S p. S756
artikel
487 Cognitive and functional assessment of elderly quilombola communities in the northeastern state of Goias, Brazil Lopes, Danielly
2012
8 4S p. P142
artikel
488 Cognitive and functional impairment associated with lifestyles in Brazilian elderly subjects Barcelos-Ferreira, Ricardo
2012
8 4S p. S749-S750
artikel
489 Cognitive and functional impairment in a community sample in Florianópolis, Brazil: High prevalence and diversity of clinical conditions associated Lopes, Marcos
2012
8 4S p. P137-P138
artikel
490 Cognitive assessment during Medicare annual wellness visits Boustani, Malaz
2012
8 4S p. P1
artikel
491 Cognitive assessment of mild cognitive impairment McGuinness, Bernadette
2012
8 4S p. P353
artikel
492 Cognitive assessments as estimators of neocortical beta-amyloid burden in the AIBL cohort Burnham, Samantha
2012
8 4S p. P130-P131
artikel
493 Cognitive behavioral therapy to combat hopelessness and low self-efficacy in Alzheimer's disease Helcer, Jacqueline
2012
8 4S p. P376
artikel
494 Cognitive change across the life span: Recent insights Shatil, Evelyn
2012
8 4S p. P437
artikel
495 Cognitive change and Aβ deposition in MCI subjects studied with serial 18F-florbetaben PET over 2 years Ong, Kevin
2012
8 4S p. P22-P23
artikel
496 Cognitive change and beta-amyloid deposition in MCI subjects studied with serial 18F-Florbetaben PET over 2 years Ong, Kevin
2012
8 4S p. P258
artikel
497 Cognitive decline and regional brain perfusion in Alzheimer's disease using single photon emission computed tomography: A retrospective study Rakesh, Balachandar
2012
8 4S p. P508-P509
artikel
498 Cognitive decline as a quadratic function of free tri-iodothyronine levels in Alzheimer's disease Leyhe, Thomas
2012
8 4S p. P505
artikel
499 Cognitive decline in Asian patients with CADASIL Lee, Jung Seok
2012
8 4S p. P180-P181
artikel
500 Cognitive detection of preclinical Alzheimer's disease Lau, Hiuyan
2012
8 4S p. P358
artikel
501 Cognitive fluctuations and sleep disordered breathing in Alzheimer's disease: A pilot study Hannesdottir, Kristin
2012
8 4S p. P547
artikel
502 Cognitive function and mobility disability in older adults with amnestic mild cognitive impairment McGough, Ellen
2012
8 4S p. P373
artikel
503 Cognitive function and oral hygiene behavior in later life Wu, Bei
2012
8 4S p. P141
artikel
504 Cognitive impairment-related alterations in brain functional connectivity Charil, Arnaud
2012
8 4S p. S754
artikel
505 Cognitively intact elderly individuals reclassified according to the new approach for Alzheimer's disease presymptomatic detection Chaves, Marcia
2012
8 4S p. P492
artikel
506 Cognitively stimulating leisure activities: A new approach for patients with mild cognitive impairment (MCI) Tesky, Valentina
2012
8 4S p. P571
artikel
507 Cognitive processing speed and diffusional kurtosis imaging (DKI) in normal aging, mild cognitive impairment (MCI) and Alzheimer's disease Benitez, Andreana
2012
8 4S p. P42
artikel
508 Cognitive processing speed and diffusional kurtosis imaging (DKI) in normal aging, mild cognitive impairment (MCI), and Alzheimer's disease (AD) Benitez, Andreana
2012
8 4S p. P506-P507
artikel
509 Cognitive resilience: APOE-e4 and mixed dementia Brusco, Luis
2012
8 4S p. S752
artikel
510 Cognitive status, APOE-ε4 status and risk of death: A report from the Einstein Aging Study (EAS) Derby, Carol
2012
8 4S p. P316-P317
artikel
511 Cognitive stimulation and APOE genotype in non-demented elderly subjects from the InveCe.Ab population study Polito, Letizia
2012
8 4S p. P499-P500
artikel
512 Cognitive testing of illiterate elderly in Brazil Nitrini, Ricardo
2012
8 4S p. P227
artikel
513 Cognitive testing on computer (C-TOC): Design, usability evaluation and validation of a novel computerized testing tool Jacova, Claudia
2012
8 4S p. P540
artikel
514 Cognitive trajectories associated with beta-amyloid deposition in the nondemented oldest-old Snitz, Beth
2012
8 4S p. P353
artikel
515 Cognitive trajectories associated with beta-amyloid deposition in the nondemented oldest-old Snitz, Beth
2012
8 4S p. P37-P38
artikel
516 Columnar microstructural changes differ between Alzheimer's disease, cerebrovascular disease and frontotemporal dementia Chance, Steven
2012
8 4S p. S754
artikel
517 Combination of gray matter density and global cognitive information as a better predictor of the conversion to Alzheimer's disease in mild cognitive impairment: A two-year follow-up study Sohn, Bo Kyung
2012
8 4S p. P17
artikel
518 Combination of gray matter density and global cognitive information as a better predictor of the conversion to Alzheimer's disease in mild cognitive impairment: A two-year follow-up study Sohn, Bo Kyung
2012
8 4S p. P328-P329
artikel
519 Combination therapy for Alzheimer's disease: Memantine and cholinesterase inhibitors Schmidtke, Klaus
2012
8 4S p. P396
artikel
520 Combined fornix degeneration and CA1 hippocampal loss predict conversion of normal to MCI Fletcher, Evan
2012
8 4S p. P433
artikel
521 Combined hemodynamic effects of Aβ protein and cerebral ischemia in a rat model of cognitive impairment: A CT perfusion study Yang, Jun
2012
8 4S p. P21-P22
artikel
522 Combined nutrient enrichment induces changes in synaptic protein expression in vitro Kamphuis, Patrick
2012
8 4S p. P417
artikel
523 Combining classical conditioning and brain-state classification for the development of a brain-computer interface (BCI) for Alzheimer's patients Liberati, Giulia
2012
8 4S p. P515
artikel
524 Common disorders demand expert care: The need for specialized professional education in disorders of dementia Kaplan, Daniel
2012
8 4S p. P430
artikel
525 Common features of comorbidities among people with dementia and mild cognitive impairment and major depressive disorders Eun, Hun-Jeong
2012
8 4S p. P489
artikel
526 Common gene networks underlying memory impairment: A comparison of pathway analysis methods in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort Ramanan, Vijay
2012
8 4S p. P682-P683
artikel
527 Communication strategies for caregivers and patients with mild-to-moderate dementia Lorell, Daryl
2012
8 4S p. P388
artikel
528 Community-based comprehensive neuropathological survey in the elderly reveals wider range of neurodegenerative pathologies than assumed Kovacs, Gabor
2012
8 4S p. P173
artikel
529 Community life withdrawal with MCI progression Kaye, Jeffrey
2012
8 4S p. P483
artikel
530 Community resources for individuals and families: Web-based support Kallmyer, Beth
2012
8 4S p. P2
artikel
531 Comparative studies of EB101, Aß1-42 active vaccine, with AN1792 Vigo, Carmen
2012
8 4S p. P183
artikel
532 Comparing memory deficits in conventional and novel memory tasks in rTg4510 mice Reed, Miranda
2012
8 4S p. P204-P205
artikel
533 Comparison between MMSE and Montreal Cognitive Assessment (MoCA) for detecting cognitive impairments in patients with Parkinson's disease: A multicenter study of Keio PD database Ohta, Kouichi
2012
8 4S p. P171
artikel
534 Comparison of beta-amyloid imaging using congo red and thioflavin T derivatives Svensson, Samuel
2012
8 4S p. P30
artikel
535 Comparison of beta-secretase between Alzheimer's disease and other neuropsychiatric disorders Konishi, Yoshihiro
2012
8 4S p. P658
artikel
536 Comparison of brief cognitive tests and CSF analysis in predicting Alzheimer's disease in mild cognitive impairment: Six-year follow-up study Palmqvist, Sebastian
2012
8 4S p. P434
artikel
537 Comparison of cognitive dysfunctions between mild cognitive impairment with and without Parkinson's disease Park, Eun Seon
2012
8 4S p. S777-S778
artikel
538 Comparison of cognitive screening measures for primary care Kane, Robert
2012
8 4S p. P370
artikel
539 Comparison of florbetapir-PET scans to postmortem beta-amyloid histopathology in 59 autopsy cases Skovronsky, Daniel
2012
8 4S p. P90-P91
artikel
540 Comparison of neuropsychological test scores among English and Spanish speakers in a multi-regional sample of cognitively normal subjects Besser, Lilah
2012
8 4S p. P548
artikel
541 Comparison of performance of early diagnostics of Alzheimer's disease between volume and thickness measurements of medial temporal structures using structural MRI Matsuda, Hiroshi
2012
8 4S p. P334-P335
artikel
542 Comparison of protein concentrations in serum versus plasma from Alzheimer's patients Barber, Robert
2012
8 4S p. P284
artikel
543 Comparison of the prevalence of neuropsychiatric behaviors between amnestic and nonamnestic MCI subjects Apostolova, Liana
2012
8 4S p. P135
artikel
544 Comparison of the ‘word’ vs. ‘picture’ versions of the free and cued selective reminding test (FCSRT) in older adults Zimmerman, Molly
2012
8 4S p. P367
artikel
545 Comparison of three diagnostic methods for determining amyloid positivity in cognitively intact elderly controls : Flutemetamol in Flander's Aging population (FLUFLAG study) Vandenberghe, Rik
2012
8 4S p. P328
artikel
546 Comparison of toxic beta-amyloid oligomer inhibitors for rescuing memory deficits in APP transgenic mice Muhs, Andreas
2012
8 4S p. P224-P225
artikel
547 Comparison of visual and quantitative florbetapir-PET reads in subjects with early Alzheimer's disease for assessing amyloid burden Peng, Yahong
2012
8 4S p. P454-P455
artikel
548 Comparison of visual and quantitative florbetapir-PET reads in subjects with early Alzheimer's disease for assessing amyloid burden Wyman, Bradley
2012
8 4S p. P38-P39
artikel
549 Comparisons of patient characteristics in subpopulations of the OPtimising Transdermal Exelon In Mild-to-moderate Alzheimer's disease (OPTIMA) study Frolich, Lutz
2012
8 4S p. P603
artikel
550 Comparison to the rate of cognitive decline in early-and late-onset Alzheimer's disease Yun, Sunghwan
2012
8 4S p. P503-P504
artikel
551 Complementary mechanisms of memantine and the cholinesterase inhibitors in the treatment of Alzheimer's disease: The 3-neurone model Parsons, Christopher
2012
8 4S p. P711
artikel
552 Comprehensive molecular genetic analysis of Alzheimer's risk loci Sleegers, Kristel
2012
8 4S p. P78
artikel
553 Compromised cerebral autoregulation in patients with mild cognitive impairment Liu, Jie
2012
8 4S p. P483-P484
artikel
554 Computational studies on the stability of C-terminal beta-amyloid dimer and mutants Epa, Vidana
2012
8 4S p. P718
artikel
555 COMT VAL158MET polymorphism, dementia risk and cognitive development in a prospective population-based aging study in Germany Wagner, David
2012
8 4S p. P722
artikel
556 Concordance of self-reported memory symptoms, informant-reported symptoms and objective memory performance in a community sample O'Brien, Jackie
2012
8 4S p. P482-P483
artikel
557 Concurrent validity of the Alzheimer's Questionnaire (AQ) Malek-Ahmadi, Michael
2012
8 4S p. P551
artikel
558 Conditional components of Helicobacter pylori induces tau hyperphosphorylation and cognitive impairment Wang, Xiulian
2012
8 4S p. P468-P469
artikel
559 Confrontation naming deficits are associated with amyloidosis in early MCI and with synaptic dysfunction in late MCI and Alzheimer's disease: An [18F]AV45/[18F]FDG-PET study Leuzy, Antoine
2012
8 4S p. P507-P508
artikel
560 Connectivity within the default mode network is related to working memory performance in young but not elderly healthy adults Yakushev, Igor
2012
8 4S p. P81
artikel
561 Connectivity within the default mode network is related to working memory performance in young but not elderly healthy adults Yakushev, Igor
2012
8 4S p. P701
artikel
562 Conquering Alzheimer's caregiver stress through faith and education Mazmanian, Victor
2012
8 4S p. P382
artikel
563 Construct validity of MoCA subscales in a population-based sample Hayden, Kathleen
2012
8 4S p. P362-P363
artikel
564 Contents 2012
8 4S p. A2-A5
artikel
565 Contribution of Alzheimer's biomarkers in the diagnosis of Alzheimer's disease in nonamnestic presentations Belin, Catherine
2012
8 4S p. P121
artikel
566 Contribution of tauopathy to bioplar disorders: Clinical and pathological studies Saito, Yuko
2012
8 4S p. P593
artikel
567 Controversies of neurobiological correlates of apathy in Alzheimer's disease: A systematic review Stella, Florindo
2012
8 4S p. P514-P515
artikel
568 Conventional and advanced imaging for in vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism Mangalore, Sandhya
2012
8 4S p. P696-P697
artikel
569 Coordinated proteasome and lysosome retrograde axonal transport is regulated by kinesin-1 clustering at projection ends Otero, Maria Gabriela
2012
8 4S p. P435-P436
artikel
570 Coping well: Counseling to promote individual and caregiver wellness—A counseling program for MCI/dementia patients, caregivers and families Shaw, Edward
2012
8 4S p. P565-P566
artikel
571 Correcting for volumetric changes reveals novel patterns of glucose metabolism in the Alzheimer's brain McQuail, Joseph
2012
8 4S p. P694-P695
artikel
572 Correlating the frontal presentation of Alzheimer's disease with frontal metabolism as measured by FDG-PET Woodward, Michael
2012
8 4S p. P163
artikel
573 Correlation between diffusion weighted imaging-apparent diffusion coefficient and clinical scores in mild-to-moderate Alzheimer's disease Bracoud, Luc
2012
8 4S p. P74
artikel
574 Correlation between DWI-ADC and clinical scores in mild-to-moderate Alzheimer's disease Bracoud, Luc
2012
8 4S p. P118-P119
artikel
575 Correlation of cerebrospinal fluid cytokines with cortical microglia densities in clinicopathological Alzheimer's disease and cognitively normal individuals Dugger, Brittany
2012
8 4S p. P286
artikel
576 Correlation of CSF beta-amyloid and tau with postoperative delirium in patients undergoing hip fracture surgery Oh, Esther
2012
8 4S p. P287
artikel
577 Cortical measures associated with cardiovascular risk and disease Cardenas, Valerie
2012
8 4S p. P623
artikel
578 Cortical thickness analysis in Alzheimer's onset Lebed, Evgeniy
2012
8 4S p. P157-P158
artikel
579 Cortical thinning in early-stage and late-stage amnestic mild cognitive impairment Ye, Byoung Seok
2012
8 4S p. P329-P330
artikel
580 Corticotropin-releasing hormone alters Aβ42 production via gamma-secretase Park, Hyo-Jin
2012
8 4S p. P639
artikel
581 Cost attributable to Alzheimer's disease in Germany Brüggenjürgen, Bernd
2012
8 4S p. P237
artikel
582 Co-treatment with memantine and compound 21, an angiotensin II type 2 receptor agonist, prevents cognitive decline in type 2 diabetic mice Mogi, Masaki
2012
8 4S p. P707
artikel
583 CREB regulates the expression of neuronal glucose transporter 3: A mechanism leading to impaired brain glucose uptake in Alzheimer's disease Jin, Nana
2012
8 4S p. P292
artikel
584 Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study Kinnunen, Kirsi
2012
8 4S p. P23
artikel
585 Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study Kinnunen, Kirsi
2012
8 4S p. P338-P339
artikel
586 Cross-training of auditory and visual brain training software program improves cognition and alters plasma BDNF levels in healthy older adults Shah, Tejal
2012
8 4S p. P99
artikel
587 Cross-vendor implementation and test-retest analysis of ADNI2 functional MRI (fMRI) and diffusion tensor imaging (DTI) sequences for multicenter clinical trials in Alzheimer's disease Marais, Lea
2012
8 4S p. P339
artikel
588 CSF Aβ 1-42 levels and glucose metabolism in Alzheimer's disease Dumurgier, Julien
2012
8 4S p. P265
artikel
589 CSF amyloid lowering in human volunteers after 14 days’ oral administration of the novel BACE1 inhibitor E2609 Albala, Bruce
2012
8 4S p. S743
artikel
590 CSF biomarkers and disease progression in an interrupted MCI trial Peters, Oliver
2012
8 4S p. P268
artikel
591 CSF neurofilament light proteins and cognitive performance in middle-aged adults at increased risk for Alzheimer's disease Carlsson, Cynthia
2012
8 4S p. S753-S754
artikel
592 CSF α-synuclein, BETA-AMYLOID 1-42 and tau proteins: Relationship to clinical parameters in early Parkinson's disease Kang, Ju Hee
2012
8 4S p. S766-S767
artikel
593 CTNNA3, CAPRIN2 and SPG20 are significantly associated with Alzheimer's disease in preliminary analyses of a genome-wide association study in African-Americans Reitz, Christiane
2012
8 4S p. P100
artikel
594 Culture matters: Clarifying the effect of ethnicity on memory and attention and its implications for assessment of Alzheimer's disease Khan, Katija
2012
8 4S p. P546
artikel
595 Curcumin modulation of molecular chaperones in amyloidogenic models of neurodegenerative diseases Maiti, Panchanan
2012
8 4S p. P226
artikel
596 Current change in Alzheimer's disease care in Quebec: From the proposed action plan to innovative approaches in family medicine groups (FMGs) Bergman, Howard
2012
8 4S p. P442-P443
artikel
597 Cystatin-C predicts risk of dementia and cognitive decline in older Mexican-Americans Haan, Mary
2012
8 4S p. P255-P256
artikel
598 Daily-life functional instruments to identify mild cognitive impairment Memoria, Claudia
2012
8 4S p. P355
artikel
599 Davunetide affects axonal transport in vivo Gozes, Illana
2012
8 4S p. P243-P244
artikel
600 Deciphering the cortical thickness signature: Biomarker for Alzheimer's disease or for memory? Meier, Irene
2012
8 4S p. P273
artikel
601 Decreased serum angiogenin in Alzheimer's disease Kim, Dohoon
2012
8 4S p. P117
artikel
602 Deep resequencing of 9 confirmed late-onset Alzheimer's disease (LOAD) loci identifies multiple genomic regions with potentially functional variants Haines, Jonathan
2012
8 4S p. P734-P735
artikel
603 Deep resequencing of GWAS loci associated with Alzheimer's disease Jin, Sheng Chih
2012
8 4S p. P735
artikel
604 Default mode network activation and prose recall performance Vidoni, Eric
2012
8 4S p. P511
artikel
605 Defects in p21-activated kinase (PAK) in Alzheimer's disease: A causal role? Arsenault, Dany
2012
8 4S p. P729-P730
artikel
606 Defining an optimal approach for evaluating regional metabolism with 18F-FDG-PET imaging: Anatomical versus probabilistic volumes of interest Soucy, Jean-Paul
2012
8 4S p. P20-P21
artikel
607 Definition of harmonized protocol for hippocampal segmentation Boccardi, Marina
2012
8 4S p. P257-P258
artikel
608 Definition of harmonized protocol for hippocampal segmentation Boccardi, Marina
2012
8 4S p. P23-P24
artikel
609 Degeneration of cholingeric afferent in a transgenic mouse model of Alzheimer's disease: Lack of correlation with proximity to amyloid plaques Chen, Gang
2012
8 4S p. S770
artikel
610 Deletion of microRNA-33 decreases beta-amyloid levels in the brain Kim, Jungsu
2012
8 4S p. P259
artikel
611 Delusions of theft in patients with dementia Ueno, Asako
2012
8 4S p. P378
artikel
612 Dementia care knowledge needs of a first nation community: A success story Abram, Joel
2012
8 4S p. P431
artikel
613 Dementia in advanced aging: A manifestation of many different brain diseases Nelson, Peter
2012
8 4S p. P138
artikel
614 Dementia is associated with increased risk of hospital readmission within 30 days of discharge Daiello, Lori
2012
8 4S p. P564
artikel
615 Dementia observed 30 days after stroke Shigematsu, Kazuo
2012
8 4S p. P734
artikel
616 Dementia with Lewy bodies and dementia with Alzheimer's disease: Effect on frontal lobe activity Katayama, Sadao
2012
8 4S p. S767
artikel
617 Demethylation of PP2A: A novel target for tau modulating therapeutics Braithwaite, Steven
2012
8 4S p. P637
artikel
618 Demographic and health-related characteristics of elders with mild cognitive impairment in Seoul City Park, Myonghwa
2012
8 4S p. P317
artikel
619 Dendritic and spinal pathology in the visual cortex in Alzheimer's disease Baloyannis, Stavros
2012
8 4S p. P299
artikel
620 Depression coexisting with Alzheimer's disease Rabins, Peter
2012
8 4S p. P2
artikel
621 Depression in patients screened for Alzheimer's disease clinical trials Hua, Yue Lisa
2012
8 4S p. P558
artikel
622 Depression, salivary cortisol and brain atrophy in a population-based cohort of old persons without dementia: The Ages-Reykjavik Study Sigurdsson, Sigurdur
2012
8 4S p. P731-P732
artikel
623 Depressive symptoms and cognitive functioning in Type 2 diabetes: A pooled analysis of three observational studies Koekkoek, Paula
2012
8 4S p. P502
artikel
624 Deregulation of hypothalamo-pituitary-adrenal axis functions in an Alzheimer's disease rat model: Disruption of the glucocorticoid receptors nucleocytoplasmic shuttling Givalois, Laurent
2012
8 4S p. P473
artikel
625 Deregulation of miRNAs suggest the activation of a neuronal protective mechanism during preclinical stages of prion disease Majer, Anna
2012
8 4S p. P172
artikel
626 Deregulation of mitochondrial calcium and apoptotic signaling via the RanBP9-cofilin pathway in neurons Roh, Seung-Eon
2012
8 4S p. P304
artikel
627 Deregulation of PP2A and hyperphosphorylation of tau protein following onset of diabetes in NOD mice El Khoury, Noura B.
2012
8 4S p. P459
artikel
628 Desalted laminaria japonica improves behavioral and neurochemical responses in the Alzheimer's disease animal model An, Yongho
2012
8 4S p. P377-P378
artikel
629 Designing an abridged Montreal Cognitive Assessment for more efficient cognitive screening Bocti, Christian
2012
8 4S p. P539
artikel
630 Designing and validating a questionnaire to assess the impact of caregiving on patients with dementia in Colombia Vargas, Juan
2012
8 4S p. P560
artikel
631 Design, synthesis, and biological evaluation of novel fused-ring systems to treat Alzheimer's disease Osman, Wesseem
2012
8 4S p. P581-P582
artikel
632 Detecting preclinical markers of dementia: The power of sustained attention and mind-wandering Jackson, Jonathan
2012
8 4S p. P287
artikel
633 Detecting reliable change in cognitive and functional measures of mild cognitive impairment and Alzheimer's disease Moelter, Stephen
2012
8 4S p. P634
artikel
634 Detection and treatment of Lewy body disease (LBD) with subclinical cognitive dysfunction Ohtomo, Ryo
2012
8 4S p. P171
artikel
635 Detection of dissociated autoantibody against beta-amyloid in CSF and plasma using bridging ELISA Shim, Kyu Hwan
2012
8 4S p. P282
artikel
636 Detection of PCC functional connectivity characteristics in subcortical vascular mild cognitive impairment: A resting-state fMRI study Yin, Han
2012
8 4S p. P596-P597
artikel
637 Detection of phosphorylated α-snynuclein monomer and oligomer in blood plasma and cerebrospinal fluid of Parkinson's patients Shim, Kyu Hwan
2012
8 4S p. P282
artikel
638 Determining the needs of informal caregivers for smart home user interfaces: A first look Hwang, Amy
2012
8 4S p. P181-P182
artikel
639 Developing a highly efficient and economic assay to measure beta-amyloid(1-40) and (1-42) in body fluids and tissue lysates Gurinovich, Oleg
2012
8 4S p. P286-P287
artikel
640 Developing a national institutional review board for neurodegenerative diseases Khachaturian, Ara
2012
8 4S p. P141
artikel
641 Developing a National Institutional Review Board for Neurodegenerative Diseases Snyder, Peter J.
2012
8 4S p. S748
artikel
642 Development and analytical validation of a novel assay for detection of human Aβ1-42 peptide in human CSF Berisha, Flora
2012
8 4S p. P275-P276
artikel
643 Development and analytical validation of a novel assay for measurement of total tau in human CSF Dunty, Jill
2012
8 4S p. P276
artikel
644 Development and application of a mathematical model of modulation of cerebrospinal fluid Aβ40 after treatment with gamma- and beta-secretase inhibitors Kleijn, Huub Jan
2012
8 4S p. P223
artikel
645 Development of a CAA-specific amyloid imaging tracer Han, Byung-Hee
2012
8 4S p. P10
artikel
646 Development of a cerebral amyloid angiopathy–specific amyloid imaging tracer Han, Byung-Hee
2012
8 4S p. P59-P60
artikel
647 Development of a gold nanoparticle ELISA to detect low-abundant proteins in cerebrospinal fluid for diagnosis of Alzheimer's disease Müller, Mareike
2012
8 4S p. P273
artikel
648 Development of a multidisciplinary model of dementia care for use in primary care networks in Alberta Parmar, Jasneet
2012
8 4S p. P443-P444
artikel
649 Development of an induced pluripotent stem cell (iPSC) Alzheimer's disease model using PSEN1 mutant fibroblasts Sproul, Andrew A.
2012
8 4S p. P724
artikel
650 Development of an induced pluripotent stem cell (iPSC) Alzheimer's disease model using PSEN1 mutant fibroblasts Sproul, Andrew
2012
8 4S p. P310
artikel
651 Development of an Internet-based dementia risk assessment Brandt, Jason
2012
8 4S p. P322
artikel
652 Development of an in vivo magnetic resonance imaging method to evaluate hippocampus volume in APP and PS1 transgenic mice Hayes, Kerrie
2012
8 4S p. P153-P154
artikel
653 Development of a questionnaire on everyday navigational ability to assess topographical disorientation in Alzheimer's disease Pai, Ming-Chyi
2012
8 4S p. P381
artikel
654 Development of a robust MRI metric for longitudinal studies in Alzheimer's disease Vemuri, Prashanthi
2012
8 4S p. P85
artikel
655 Development of a screening algorithm for Alzheimer's disease using the categorical fluency test Chi, Yeon Kyung
2012
8 4S p. P371-P372
artikel
656 Development of a simple and sensitive method for measurements of Aß, and its application to measure Aß contents in human nasal smear Nanjo, Toshifumi
2012
8 4S p. P120-P121
artikel
657 Development of a standardized approach to disclosing amyloid imaging results in MCI Lingler, Jennifer
2012
8 4S p. P422
artikel
658 Development of dementia in a cohort of elderly frequent attenders to ambulatory health services Seinhart, Daniel
2012
8 4S p. P122-P123
artikel
659 Development of DEMQOL-U and DEMQOL-Proxy-U: Generation of preference-based indices from DEMQOL and DEMQOL-Proxy for use in economic evaluation Banerjee, Sube
2012
8 4S p. P238
artikel
660 Development of novel SPECT radiotracers for Alzheimer's disease Barnham, Kevin
2012
8 4S p. P63-P64
artikel
661 Development of tau proteolytic activity as a target for drug discovery Moe, James
2012
8 4S p. P458-P459
artikel
662 Dexmedetomidine induces tau hyperphosphorylation in the mouse hippocampus Whittington, Robert
2012
8 4S p. P461-P462
artikel
663 Dextromethorphan HBr and quindine sulphate (Nuedexta) for the treatment of pseudobulbar affect (PBA) in an Alzheimer's disease patient residing in a nursing home: A case report Shua-Haim, Joshua
2012
8 4S p. P723
artikel
664 DHEAS and cognitive function in post-menopausal women: The Women's Healthy Aging Study Chua, Charlene
2012
8 4S p. P575
artikel
665 Diabetes characteristics and cognitive compromise: Implications for non-diabetic individuals Beeri, Michal Schnaider
2012
8 4S p. P254
artikel
666 Diagnosing mild cognitive impairment due to Alzheimer's disease using biomarkers of beta-amyloid protein and neuronal injury Hatashita, Shizuo
2012
8 4S p. P346
artikel
667 Diagnostic accuracy of EEG in differential diagnosis between controls, Alzheimer's disease, Lewy body dementia, and Parkinson's disease dementia Snædal, Jón
2012
8 4S p. P107
artikel
668 Diagnostic utility of Korean category verbal performance in Alzheimer's disease Lee, Ho-Won
2012
8 4S p. P358-P359
artikel
669 Diagnostic value of molecular imaging in a memory clinic setting Ossenkoppele, Rik
2012
8 4S p. P631
artikel
670 Diet, neuroimaging biomarkers and Alzheimer's disease: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing Gardener, Samantha
2012
8 4S p. P503
artikel
671 Difference of clinical and cognitive functions in MCI according to the presence of depression Shim, YongSoo
2012
8 4S p. P487
artikel
672 Differences between clinical guidelines and daily care for dementia in Germany: A comparison based on health services research data van den Bussche, Hendrik
2012
8 4S p. P443
artikel
673 Differences in clinical profiles of patients with mild cognitive impairment compared with patients with memory complaints Porto, Fábio
2012
8 4S p. P543
artikel
674 Differences in dementia presentation among elderly Asians compared to non-Asians Wong, Roger
2012
8 4S p. P325
artikel
675 Differences in neuropsychological performance according to neuropsychiatric symptoms in patients with Alzheimer's disease Makino, Taeko
2012
8 4S p. S773
artikel
676 Differences in pathways used for beta-amyloid uptake by adult human astrocytes and microglia? Mulder, Sandra
2012
8 4S p. P642-P643
artikel
677 Differences in regional cerebral glucose metabolism between PiB-positive and -negative amnestic mild cognitive impairment: Results from J-ADNI Ishii, Kazunari
2012
8 4S p. P161-P162
artikel
678 Different activated microglial response in human hippocampus during Alzheimer's disease progression Gutierrez, Antonia
2012
8 4S p. P299-P300
artikel
679 Different atrophic patterns of the brain in ALS with normal cognition according to onset-type Kim, Hee-Jin
2012
8 4S p. S767
artikel
680 Different CSF biomarker patterns in incipient Alzheimer's disease and vascular dementia Bjerke, Maria
2012
8 4S p. S750-S751
artikel
681 Differential correlation of amyloid binding with hippocampal subfield volume loss in cognitively normal participants Sheline, Yvette
2012
8 4S p. P351-P352
artikel
682 Differential correlation of amyloid binding with hippocampal subfield volume loss in cognitively normal participants Sheline, Yvette I.
2012
8 4S p. P4-P5
artikel
683 Differential diagnosis among Alzheimer's disease, frontotemporal disease and healthy aging: Comparative study using subcortical features Raamana, Pradeep
2012
8 4S p. P163-P164
artikel
684 Differential effects of presenilin mutations linked to familial Alzheimer's disease on intracellular Ca2+ stores: A single-organelle FRET-based analysis Capitanio, Paola
2012
8 4S p. P292
artikel
685 Differential impact of apolipoprotein E genotype on distributions of amyloid load and glucose metabolism in Alzheimer's disease Van der Flier, Wiesje
2012
8 4S p. P618
artikel
686 Differential influence of apolipoprotein and TOMM40 on hippocampal volume Ferencz, Beata
2012
8 4S p. P659
artikel
687 Differential interaction of beta-amyloid-42 and beta-amyloid-40 to plasma membrane lipids Althoff, Veit
2012
8 4S p. P241
artikel
688 Differential microglial expression of new Alzheimer's disease associated genes MS4A4A and MS4A6A Kofler, Julia
2012
8 4S p. P253
artikel
689 Differentiating clinicopathologic and genetic aspects of hippocampal sclerosis in Alzheimer's disease from limbic predominant Alzheimer's disease and “pure” hippocampal sclerosis Graff-Radford, Neill
2012
8 4S p. P620-P621
artikel
690 Different patterns of cortical atrophy in early- and late-onset Alzheimer's disease Möller, Christiane
2012
8 4S p. P14
artikel
691 Different patterns of cortical atrophy in early- and late-onset Alzheimer's disease Möller, Christiane
2012
8 4S p. P157
artikel
692 Different performance on word list learning and the story recall test in patients with Alzheimer's disease, mild cognitive impairment and subjective memory impairment Park, Kyung Won
2012
8 4S p. P364
artikel
693 Different sensitivity of neuropsychological screening tests ACE-R and MMSE in patients with MCI and dementia Koson, Peter
2012
8 4S p. P369
artikel
694 Diffusion tensor imaging as a diagnostic tool for Alzheimer's disease Yang, Dong Won
2012
8 4S p. P37
artikel
695 Dimebon in Alzheimer's disease: Summary and contrast of three efficacy trials Doody, Rachelle
2012
8 4S p. P456
artikel
696 Disclosing amyloid imaging results Karlawish, Jason
2012
8 4S p. P423
artikel
697 Disclosure of amyloid status in secondary prevention trials for Alzheimer's disease Sperling, Reisa
2012
8 4S p. P422-P423
artikel
698 Disclosure of APOE genotype to persons with mild cognitive impairment (MCI) Green, Robert
2012
8 4S p. P422
artikel
699 Discordance for hippocampal atrophy and amyloid burden in amnestic mild cognitive impairment may identify distinct subgroups of patients Novak, Gerald
2012
8 4S p. P481-P482
artikel
700 Discrepant diagnostic classification with AV45-PET and FDG-PET of clinically diagnosed Alzheimer's patients in the Alzheimer's Disease Neuroimaging Initiative Foster, Norman
2012
8 4S p. P109-P110
artikel
701 Disease progression in patients with mild-to-moderate Alzheimer's disease treated with galantamine: Results of a two-year open-label study Gaudig, Maren
2012
8 4S p. P592
artikel
702 Disequilibrium of APOE levels between serum and cerebrospinal fluid in Alzheimer's patients Laske, Christoph
2012
8 4S p. P117
artikel
703 Disordered ‘instrumental’ abilities and impaired IADL as potent predictors of imminent dementia in persons with cognitive impairment Luck, Tobias
2012
8 4S p. S751-S752
artikel
704 Disrupted cortical hubs in functional brain networks in early-stage Alzheimer's disease Dai, Zhengjia
2012
8 4S p. P536-P537
artikel
705 Disrupted functional connectivity in autosomal dominant Alzheimer's disease: Preliminary findings from the DIAN study Chhatwal, Jasmeer
2012
8 4S p. P244-P245
artikel
706 Disrupted functional integrity between task-positive and task-negative networks in the early stages of Alzheimer's disease Wang, Zhiqun
2012
8 4S p. P66
artikel
707 Disrupted functional integrity between task-positive and task-negative networks in the early stages of Alzheimer's disease Wang, Zhiqun
2012
8 4S p. P6
artikel
708 Disrupted nuclear transport: A central event in Alzheimer's pathophysiology Mastroeni, Diego
2012
8 4S p. P657
artikel
709 Disruption of cognitive flexibility by MK-801 and scopolamine in an operant reversal learning task in the rat Hernier, Anne Marie
2012
8 4S p. P210
artikel
710 Disruption of limbic white matter tracts in patients with mild cognitive impairment Zhang, Rong
2012
8 4S p. P336
artikel
711 Distinct age-dependent tau changes in Type 2 diabetic rats Park, Sun Ah
2012
8 4S p. P463
artikel
712 Distinct neuropsychological profiles of mild cognitive impairment: Effects of the MCI classification scheme on empirically derived subgroups Clark, Lindsay
2012
8 4S p. P364-P365
artikel
713 Distribution of BACE1 in the rodent, monkey and human brain Gobbi, Luca
2012
8 4S p. P154
artikel
714 Distribution of beta-amyloid peptides in leptomeningeal amyloid deposits and cerebrospinal fluid in patients with Alzheimer's disease: A mirror image Catania, Marcella
2012
8 4S p. P655-P656
artikel
715 Distribution of microbleeds in patients with cognitive impairments of the Alzheimer's and subcortical vascular types based on PiB-PET imaging Park, Jae Hyun
2012
8 4S p. P517-P518
artikel
716 Disturbances of innate immunity in Alzheimer's disease: Possible therapeutic approach Leszek, Jerzy
2012
8 4S p. P301
artikel
717 Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ-40/42, alpha-synuclein and DJ-1 in healthy volunteers Ereshefsky, Larry
2012
8 4S p. P114-P115
artikel
718 Diverging PIB and FDG covariance patterns across clinical variants of Alzheimer's disease Lehmann, Manja
2012
8 4S p. P632
artikel
719 Diverging PiB and FDG covariance patterns across clinical variants of Alzheimer's disease Lehmann, Manja
2012
8 4S p. P64-P65
artikel
720 Divided attention deficits in prodromal Alzheimer's disease at the stage of amnestic mild cognitive impairment Brammer, Michael
2012
8 4S p. P33
artikel
721 DNA-metiltransferase polymorphism in Alzheimer's disease Pezzi, Julio Carlos
2012
8 4S p. P670
artikel
722 Does a history of migraines increase the risk of Alzheimer's disease or vascular dementia? Morton, Rebecca
2012
8 4S p. P504
artikel
723 Does a multicomponent exercise program improve dual-task performance in amnestic mild cognitive impairment? A randomized controlled trial Makizako, Hyuma
2012
8 4S p. P570-P571
artikel
724 Does a positive PIB scan always mean Alzheimer's disease? Chertkow, Howard
2012
8 4S p. P125
artikel
725 Does a single low dose of ionizing radiation induce Alzheimer's disease-like alterations in mice? Wang, Bing
2012
8 4S p. S787
artikel
726 Does daily walking activity reflect activity withdrawal related to apathy? Tung, James
2012
8 4S p. P236-P237
artikel
727 Does general anaesthesia exacerbate Alzheimer's disease? Evered, Lisbeth
2012
8 4S p. P208-P209
artikel
728 Does multilingualism reduce the risk or delay the onset of dementia?: Findings from the Nun Study Hack, Erica
2012
8 4S p. P504
artikel
729 Does neuropathology mediate the association between hypertension and dementia in the oldest-old? Corrada, Maria
2012
8 4S p. P449
artikel
730 Does the length of time between traumatic brain injury and the onset of Alzheimer's disease affect the rate of cognitive and functional progression?: The Cache County Dementia Progression Study Gilbert, Mac
2012
8 4S p. P500-P501
artikel
731 Dominant left laterality of EEG in patients with TGA Kwon, Yooseok
2012
8 4S p. P133-P134
artikel
732 Donepezil for memory decline in mild cognitive impairment: Efficacy and limitations in a seven-year follow-up study Koide, Reiko
2012
8 4S p. P370
artikel
733 Donepezil in the treatment of Alzheimer's disease: Results from a routine clinical practice setting Ramdane, Said
2012
8 4S p. P716-P717
artikel
734 Donepezil treatment's late effects on cytokines release from lymphocytes of Alzheimer's disease patients Stamouli, Evaggelia
2012
8 4S p. P111
artikel
735 Do outpatients with dementia or delirium receive recommended monitoring for metabolic side effects when prescribed antipsychotics? Mittal, Dinesh
2012
8 4S p. P712
artikel
736 Dose-dependent effects of dietary folate, vitamin B-12 and vitamin B-6 on plasma lipid profile in rats van Wijk, Nick
2012
8 4S p. P418
artikel
737 Dose-dependent effects of small-vessel disease MRI markers on regional cortical thinning and structural connectivity Ye, Byoung Seok
2012
8 4S p. P156-P157
artikel
738 Driving and early Alzheimer's disease Cannon, Rex
2012
8 4S p. P129
artikel
739 Drug repositioning for Alzheimer's disease and effects of beta-amyloid on the proteome in cell culture for Alzheimer's disease Modak, Swananda
2012
8 4S p. S757
artikel
740 DTI reflects symptomatology and discriminates Parkinson's from Alzheimer's MCI and normal controls Auning, Eirik
2012
8 4S p. S767-S768
artikel
741 Dual cognitive screening for dementia: Preliminary case ascertainment in the antioxidant Alzheimer's prevention (PREADViSE) trial Abner, Erin
2012
8 4S p. P144
artikel
742 Dual tasking and functional mobility in Alzheimer's disease, mild cognitive impairment and normal aging: Correlation with executive function Borges, Sheila
2012
8 4S p. P131
artikel
743 Duplications in chr15q11 are associated with late-onset Alzheimer's disease in the Caucasian population Lin, Chiao-Feng
2012
8 4S p. P665-P666
artikel
744 Dynamic biomarker model in Alzheimer's disease: Longitudinal analysis of hippocampal volume shows linear decline Mouiha, Abderazzak
2012
8 4S p. P346-P347
artikel
745 Dyscravia and primary progressive aphasia Senaha, Mirna
2012
8 4S p. P169
artikel
746 Dysphagia in individuals with Alzheimer's disease: A systematic review of the evidence Affoo, Rebecca
2012
8 4S p. S747
artikel
747 Early and late cognitive ERP components are differentially sensitive to Alzheimer's disease and age Connell, Stephanie
2012
8 4S p. S756
artikel
748 Early identification of MCI: A five-year follow-up from age 55 to 60 Kremen, William
2012
8 4S p. P135-P136
artikel
749 Early indications of future cognitive decline: Stable controls versus MCI converters Rizk-Jackson, Angela
2012
8 4S p. P327-P328
artikel
750 Early indicators of dementia risks: Tests of cognition and achievement among the 1960 Project TALENT high school cohort McNally, James
2012
8 4S p. P238
artikel
751 Early mild cognitive impairment in the Wisconsin Registry for Alzheimer's Prevention (WRAP) Sager, Mark
2012
8 4S p. P316
artikel
752 Early mitochondrial dysfunction in the etiology of Alzheimer's disease Trushina, Eugenia
2012
8 4S p. P290-P291
artikel
753 Early-onset Alzheimer's disease associated with PSEN1 L166P mutation: An atypical clinical phenotype Ghetti, Bernardino
2012
8 4S p. P664-P665
artikel
754 Early-onset dementia: Needs of patients and carers in the early diagnostic stage Green, Theresa
2012
8 4S p. P382
artikel
755 Early-onset familial Alzheimer's disease and the definition of family: Experience with an indigenous community Mackie, Jennifer
2012
8 4S p. P667
artikel
756 Economic evaluation of the combination therapy of a cholinesterase inhibitor and memantine in Alzheimer's dementia in Switzerland Pfeil, Alena
2012
8 4S p. P387
artikel
757 Editorial Board 2012
8 4S p. A6
artikel
758 Effectiveness and safety of citicoline in mild vascular cognitive impairment: The IDEALE study Cotroneo, Antonino Maria
2012
8 4S p. S746
artikel
759 Effectiveness of an outpatient cognitive rehabilitation program in patients with acquired brain damage in Argentina: A prospective cohort study Demey, Ignacio
2012
8 4S p. P179-P180
artikel
760 Effectiveness of an outpatient cognitive stimulation program in patients with mild cognitive impairment, Alzheimer's disease and other neurodegenerative diseases in Argentina: A prospective cohort study Rojas, Galeno
2012
8 4S p. P417-P418
artikel
761 Effectiveness of galantamine in patients with mild-to-moderate dementia: 12 months' outcome data Gaudig, Maren
2012
8 4S p. P592
artikel
762 Effectiveness of two protocols for treating nursing home residents with advanced dementia Kovach, Christine
2012
8 4S p. P196
artikel
763 Effect of Aβ burden and apolipoprotein E-ε4 on cognitive decline at 18 months in healthy older adults Lim, Yen Ying
2012
8 4S p. P439
artikel
764 Effect of acute anti-amyloid monoclonal antibody ponezumab (PF-04360365) dosing on Aβ fractional clearance rate in subjects with mild Alzheimer's disease and in healthy volunteers Raunig, David
2012
8 4S p. P456
artikel
765 Effect of age on spatial navigation Gazova, Ivana
2012
8 4S p. P545
artikel
766 Effect of a novel BACE inhibitor in the cisterna magna ported conscious rhesus monkey model Michener, Maria
2012
8 4S p. P188-P189
artikel
767 Effect of APOE-ε4 status on the association of potential confounders and the risk of Alzheimer's disease Chen, Yen-Ching
2012
8 4S p. P720-P721
artikel
768 Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin-induced model of dementia in rats Kumar, Anil
2012
8 4S p. P195
artikel
769 Effect of combination therapy with memantine and rivastigmine transdermal patch on BPSD in patients with mild-to-moderate Alzheimer's disease: A 24-week prospective, multicenter, randomized, open-label clinical trial Na, Hae Ri
2012
8 4S p. P584
artikel
770 Effect of disrupted neural networks on the development of post-stroke dementia Lim, Jae-Sung
2012
8 4S p. P180
artikel
771 Effect of donepezil 23 mg/day on language function in patients with moderate-to-severe Alzheimer's disease (AD): Subgroup analysis of United States (U.S.)-based patients Ferris, Steven
2012
8 4S p. P591-P592
artikel
772 Effect of gene-environment interactions between APOE-ɛ4 and lifetime alcohol consumption on cognition in older adults Downer, Brian
2012
8 4S p. P136
artikel
773 Effect of lifestyle activities on Alzheimer's biomarkers and cognition Vemuri, Prashanthi
2012
8 4S p. P148
artikel
774 Effect of ponezumab on CSF biomarkers: Pooled analysis of phase IIa studies in subjects with mild-to-moderate Alzheimer's disease Cronenberger, Carol
2012
8 4S p. P111
artikel
775 Effect of the APOE-ε4 allele on longitudinal changes in cortical thickness in normal aging Madhyastha, Tara
2012
8 4S p. P702-P703
artikel
776 Effect of the APOE-ɛ4 allele on longitudinal changes in cortical thickness in normal aging Madhyastha, Tara
2012
8 4S p. P4
artikel
777 Effect of the APOE-ɛ4 allele on longitudinal changes in cortical thickness in normal aging Madhyastha, Tara
2012
8 4S p. P58
artikel
778 Effect of the C-1327T polymorphism of the human telomerase gene (hTERT) on mortality and relationships with chronic multimorbidity in old age Kalpouzos, Grégoria
2012
8 4S p. P668-P669
artikel
779 Effect of Tween-20 on levels of core biomarkers measured in human cerebrospinal fluid from patients with Alzheimer's disease or healthy control individuals White, Linda
2012
8 4S p. P118
artikel
780 Effect of white matter hyperintensity (WMH) levels on cognitive function according to Apolipoprotein E (APOE) genotype Hong, Chang Hyung
2012
8 4S p. P718-P720
artikel
781 Effects of aerobic fitness on hypoxic responsive elements Mehari, Alem
2012
8 4S p. P410
artikel
782 Effects of age and reproductive status on gene expression in the female hippocampus Mao, Zisu
2012
8 4S p. P305
artikel
783 Effects of a high-fat diet on the cerebrovasculature and neuroinflammation in an experimental model of Alzheimer's disease Martins, Isaura
2012
8 4S p. P471
artikel
784 Effects of Aβ load on task-free fMRI abnormalities in dementia with Lewy bodies Kantarci, Kejal
2012
8 4S p. P71-P72
artikel
785 Effects of anti-TNF therapy on amyloid pathology and neuroinflammation in 12-month-old arcAß transgenic mice McAfoose, Jordan
2012
8 4S p. P394
artikel
786 Effects of APOE-ε4 on regional cerebral amyloid deposition and glucose metabolism in amnestic mild cognitive impairment with amyloid pathology confirmed by PiB-PET: Results from J-ADNI Takahashi, Ryuichi
2012
8 4S p. P686
artikel
787 Effects of BACE1 inhibition on AICD production Yang, Zhixiang
2012
8 4S p. P221-P222
artikel
788 Effects of beta-amyloid load on task-free fMRI abnormalities in dementia with Lewy bodies Kantarci, Kejal
2012
8 4S p. P170-P171
artikel
789 Effects of cardiovascular risk and disease on the cerebral cortex Cardenas, Valerie
2012
8 4S p. P77
artikel
790 Effects of chronic alcohol consumption on expression levels of APP and BETA-AMYLOID-PRODUCING enzymes Gwon, A-Ryeong
2012
8 4S p. S761-S762
artikel
791 Effects of cognitive training combined with transcranial magnetic stimulation on cognitive functions and brain plasticity in patients with Alzheimer's disease Schilberg, Lukas
2012
8 4S p. P709
artikel
792 Effects of elevated plasma cholesterol on CSF lipids and Alzheimer's disease CSF biomarkers in African green monkeys Hayashi, Ikuo
2012
8 4S p. S764
artikel
793 Effects of extended-release memantine (28 mg, once daily) on language and communication abilities in a randomized trial of patients with moderate-to-severe Alzheimer's disease Tocco, Michael
2012
8 4S p. P589
artikel
794 Effects of gangetin on memory deficits, neurotransmitter levels and brain oxidativestress in the mouse models of dementia Made, Ganesh
2012
8 4S p. P196
artikel
795 Effects of Icarrin on Aβ burden in a mouse model of Alzheimer's disease Zhang, Lan
2012
8 4S p. P704
artikel
796 Effects of melatonin on cytoskeletal and synaptic proteins in an Alzheimer's mouse model O'Neal-Moffitt, Gina
2012
8 4S p. P573-P574
artikel
797 Effects of memantine in patients with moderate alzheimer's disease receiving stable doses of donepezil Molinuevo, Jose Luis
2012
8 4S p. P601
artikel
798 Effects of multicomponent exercise on cerebral hemoglobin oxygenation in older adults with amnestic mild cognitive impairment: Functional monitoring using NIR spectroscopy Park, Hyuntae
2012
8 4S p. P313-P314
artikel
799 Effects of multicomponent exercise on cognitive function in the older adults with amnestic mild cognitive impairment: A randomized control trial Shimada, Hiroyuki
2012
8 4S p. P144-P145
artikel
800 Effects of omega-3 supplementation on brain structure and function in healthy elderly subjects Witte, Veronica
2012
8 4S p. P69
artikel
801 Effects of omega-3 supplementation on brain structure and function in healthy elderly subjects Witte, Veronica
2012
8 4S p. P441
artikel
802 Effects of oral ELND005 (Scyllo-inositol) on brain scyllo-inositol and myo-inositol levels: Spectroscopy results from a phase 2 study in MILD-TO-MODERATE Alzheimer's disease Liang, Earvin
2012
8 4S p. S783-S784
artikel
803 Effects of oral ELND005 (scyllo-inositol) on neuropsychiatric symptoms in a 78-week phase 2 study in mild/moderate Alzheimer's disease (AD): Potential role of myo-inositol reduction Lyketsos, Constantine
2012
8 4S p. S771-S772
artikel
804 Effects of rivastigmine in the treatment of behavioral and psychological symptoms of Alzheimer's disease Janjic, Vladimir
2012
8 4S p. P199
artikel
805 Effects of testosterone replacement on cognition in men with low testosterone levels and mild cognitive impairment Anderson, Kirsten
2012
8 4S p. P364
artikel
806 Effects of tetrahydroxystilbene glucoside on synapses and alpha-synuclein in brains of aged mice Li, Lin
2012
8 4S p. P577
artikel
807 Effects of the apolipoprotein E genotype on intrinsic functional connectivity in young, healthy adults Matura, Silke
2012
8 4S p. P687
artikel
808 Effects of white matter hyperintensities on the volumes of right and left hippocampus in patients with Alzheimer's disease Jang, Jae-Won
2012
8 4S p. P497-P498
artikel
809 Efficacy and safety of galantamine in long-term treatment for mild cognitive impairment Zarra, Julio
2012
8 4S p. P586
artikel
810 Efficacy of a multidimensional home-based care coordination intervention for elders with memory disorders: The Maximizing Independence at Home (MIND at Home) trial Samus, Quincy
2012
8 4S p. S780
artikel
811 Efficacy of the 13.3 mg/24 h rivastigmine patch on instrumental activities of daily living in the OPtimising Transdermal Exelon In Mild-to-moderate Alzheimer's disease (OPTIMA) study: Prospective subgroup analysis by disease severity and time-to-meet decline Black, Sandra
2012
8 4S p. P603-P604
artikel
812 Efficacy, safety and tolerability of rivastigmine patch 13.3 mg/24 h (15 cm2) versus 4.6 mg/24 h (5 cm2) in patients with severe Alzheimer's disease: Results of the ACTivities of daily living and cognitION (ACTION) study Farlow, Martin
2012
8 4S p. S759
artikel
813 Eighteen-month follow-up data from the Canadian EMBRACE registry with the rivastigmine patch in patients with Alzheimer's disease Gauthier, Serge
2012
8 4S p. P600
artikel
814 Electronic consults to facilitate specialty dementia assessment and care Wild, Kathryn
2012
8 4S p. P231
artikel
815 Elementary education protects against dementia: A clinicopathological study Farfel, Jose
2012
8 4S p. P629
artikel
816 Elevated arterial stiffness and deep-brain white matter hyperintensity in patients with mild cognitive impairment Tseng, Benjamin
2012
8 4S p. P700-P701
artikel
817 Elevated depressive symptoms and dementia risk: Does the association attenuate at older ages? Glymour, M. Maria
2012
8 4S p. P732
artikel
818 Elevated diastolic blood pressure predicts poorer verbal memory in MCI adults with prediabetes Skinner, Jeannine
2012
8 4S p. P393
artikel
819 Elevated PiB precedes dementia in autosomal-dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort Benzinger, Tammie
2012
8 4S p. P687-P688
artikel
820 Elevated PiB precedes dementia in autosomal dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort Benzinger, Tammie
2012
8 4S p. P57-P58
artikel
821 Elevated serum copper level in Alzheimer's disease Lee, Dong Woo
2012
8 4S p. P469-P470
artikel
822 Emerging relationship between development and degeneration: TrkA-APP interaction as a therapeutic target in Alzheimer's disease Zhang, Qiang
2012
8 4S p. P399
artikel
823 Emotional reactivity and awareness of task performance in Alzheimer's disease Mograbi, Daniel
2012
8 4S p. P728
artikel
824 Emotional reactivity in people with Alzheimer's disease to film material depicting Alzheimer's disease versus other film material Morris, Robin
2012
8 4S p. P728
artikel
825 Encoding deficits in mild cognitive impairment predict activities of daily living Woo, Ellen
2012
8 4S p. P356
artikel
826 Encoding of novel complex visual scenes in presymptomatic Alzheimer's disease Quiroz, Yakeel
2012
8 4S p. P35
artikel
827 Encoding of novel complex visual scenes in presymptomatic Alzheimer's disease Quiroz, Yakeel
2012
8 4S p. P104
artikel
828 Endogenous cholesterol metabolites as potential Alzheimer's therapeutics Felsenstein, Kevin
2012
8 4S p. P104-P105
artikel
829 Endogenous tau contributes to Alzheimer's-like tau pathology in 3xTg mice Baglietto-Vargas, David
2012
8 4S p. P458
artikel
830 Endoplasmic reticulum (ER) stress and abnormal tau converge in a ubiquitin-related vicious cycle: Early events in neuronal damage Abisambra, Jose
2012
8 4S p. P252
artikel
831 Endoplasmic reticulum plays important roles in initiating autophagy in cultured hippocampal neurons after exposure to beta-amyloid peptide Chuen-Chung Chang, Raymond
2012
8 4S p. P252-P253
artikel
832 Endoplasmic reticulum stress links impaired insulin signaling and Alzheimer's disease Lourenço, Mychael
2012
8 4S p. P253
artikel
833 Engaging patients at high risk of dementia in multimodal cognitive health promoting activities: The ThinkingFit study Cleverley, Martin
2012
8 4S p. P220-P221
artikel
834 Enhancing antibody uptake in brain to target BACE1 Atwal, Jasi
2012
8 4S p. P95
artikel
835 Enhancing care practices for residents with dementia Campbell, Alison
2012
8 4S p. P565
artikel
836 Epigenetic mechanisms of nitric oxide and in vivo brain functional imaging Lista, Simone
2012
8 4S p. P687
artikel
837 Epigenetic mechanisms underlying the risk of Alzheimer's disease among diabetic subjects Gong, Bing
2012
8 4S p. P472
artikel
838 Epigenetic modification in metabolic syndrome-induced brain energy impairment Varghese, Merina
2012
8 4S p. P253
artikel
839 Epileptiform discharges in transgenic Alzheimer's mice correlate with impairments in spatial memory and are reduced by ethosuximide Nygaard, Haakon
2012
8 4S p. P202
artikel
840 eQTL regulation by NATs in Alzheimer's disease Myers, Amanda
2012
8 4S p. P451
artikel
841 Erlin-2 is associated with active gamma-secretase in brain Teranishi, Yasuhiro
2012
8 4S p. P241-P242
artikel
842 ERPs for animal models of Alzheimer's disease Leiser, Steven
2012
8 4S p. P726
artikel
843 ERPs for preclinical Alzheimer's disease and MCI due to Alzheimer's disease Budson, Andrew
2012
8 4S p. P726
artikel
844 ERP surface and source measures reveal age-related changes in episodic memory Freeman, Michael
2012
8 4S p. S759
artikel
845 ER stress in Alzheimer's disease and PSP: Common disease mechanism? Stutzbach, Lauren
2012
8 4S p. P460-P461
artikel
846 Erythrocyte omega-3 fatty acid concentrations and cognitive function: The Cache County Study on Memory and Aging Wengreen, Heidi
2012
8 4S p. P449
artikel
847 Establishing apolipoprotein E as a biomarker for Alzheimer's disease: Australian Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing Gupta, Veer Bala
2012
8 4S p. P110-P111
artikel
848 Establishing threshold scores and profiles of cognitive impairment for the Alzheimer's Disease Assessment Scale–Cognitive Subscale (ADAS-Cog) for patients with higher dementia (MMSE < 12), Alzheimer's disease and probable MCI Yavorsky, Christian
2012
8 4S p. P415-P416
artikel
849 Establishment of pathology center for amyotrophic lateral sclerosis/Parkinson's disease complex in Kii Peninsula Murayama, Shigeo
2012
8 4S p. P175
artikel
850 Estrone decreases the levels of beta-amyloid in the cerebral cortex and corpus callosum after brain injury Gatson, Joshua
2012
8 4S p. P185-P186
artikel
851 Ethnicity and dementia: Three challenges in diagnosing dementia Nornholm, Mikael
2012
8 4S p. P564
artikel
852 Ethno-racial differences in vascular dementia and Alzheimer's disease in Vancouver, British Columbia Hsiung, Ging-Yuek
2012
8 4S p. P139
artikel
853 Evaluating sex differences and vascular morbidities in relation to global cognitive function in incident Alzheimer's disease Gustafson, Deborah
2012
8 4S p. P496
artikel
854 Evaluation of a manualized psychoeducational program for primary caregivers of patients with Alzheimer's disease: Its impact on caregivers' quality of life and depressive symptoms—A single-blinded longitudinal study Schuster, Maria
2012
8 4S p. P566
artikel
855 Evaluation of a novel caspase-6 inhibitor as a potential treatment for Alzheimer's disease Pakavathkumar, Prateep
2012
8 4S p. P601
artikel
856 Evaluation of lymphocyte apoptosis from hypertensive patients of different ages with stroke Revnic, Cristian
2012
8 4S p. P294-P295
artikel
857 Evaluation of the Dr. Oz computer-based screening tool for cognitive dysfunction Duncan, Catherine
2012
8 4S p. P539
artikel
858 Evaluation of the effects of BACE1 inhibition on NRG1 processing in vitro and in vivo Boggs, Leonard
2012
8 4S p. P222
artikel
859 Evaluation of the efficacy and safety of the H3 antagonist ABT-288 in mild-to-moderate Alzheimer's disease Haig, George
2012
8 4S p. P601-P602
artikel
860 Evaluation of the efficacy and safety of the HSD-1 inhibitor ABT-384 in mild-to-moderate Alzheimer's disease Marek, Gerard
2012
8 4S p. P602
artikel
861 Evaluation of the etiology and progression of Alzheimer's disease utilizing transgenic mice fed a high fat diet Herculano, Bruno
2012
8 4S p. P495
artikel
862 Evaluation of the Navigation and Obstacle Avoidance Help (NOAH) system for wheelchair users with cognitive impairment Viswanathan, Pooja
2012
8 4S p. P231
artikel
863 Evaluation of the qualitative performance of PET/MR versus PET/CT in patients with Alzheimer's disease Hitz, Stefan
2012
8 4S p. P698
artikel
864 Evaluation of white matter alterations in Alzheimer's disease and normal pressure hydrocephalus as measured by diffusion weighted MRI Horinek, Daniel
2012
8 4S p. P160
artikel
865 Evening cortisol is associated with intra-individual instability in daytime napping in nursing home residents with dementia: An allostatic load perspective Woods, Lynn
2012
8 4S p. P385-P386
artikel
866 Evidence for dissociable patterns of PiB retention during early stages of amyloid accumulation Mormino, Elizabeth
2012
8 4S p. P44-P45
artikel
867 Evidence for dissociable patterns of PiB retention during early stages of amyloid accumulation Mormino, Elizabeth
2012
8 4S p. P512-P513
artikel
868 Evidence of altered TrkB pre-mRNA splicing in Alzheimer's disease Wong, Jenny
2012
8 4S p. S788-S789
artikel
869 Evidence supporting use of non-pharmacologic interventions for NPS: Where do we go from here? Whitlatch, Carol
2012
8 4S p. P80
artikel
870 Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer's disease Lee, Yoon-Jee
2012
8 4S p. S771
artikel
871 Evoked hippocampal supralinear intracellular calcium responses are absent in 3xTg Alzheimer's mice Morley, Shane
2012
8 4S p. P409
artikel
872 Evolution of memory disorders in elderly people who recover, remain stationary and develop dementia Zarra, Julio
2012
8 4S p. P314
artikel
873 EVP-6124, a selective alpha-7 partial agonist, has positive effects on cognition and clinical function in mild-to-moderate Alzheimer's disease patients: Results of a six-month, double-blind, placebo controlled, dose ranging study Hilt, Dana
2012
8 4S p. S746
artikel
874 Examining the discontinuation of cholinesterase inhibitor therapy from the perspectives of Alzheimer's disease caregivers and physicians Smith, Andre
2012
8 4S p. P427
artikel
875 Executive functions and occupational performance in Brazilian older adults with mild cognitive impairment Chaves, Giseli
2012
8 4S p. P373
artikel
876 Exercise prevents gray matter atrophy in anterior cingulate and supplementary motor area in the elderly Tamura, Masashi
2012
8 4S p. P147
artikel
877 Exome sequencing in Alzheimer's disease: Do rare variants play a role in risk? Guerreiro, Rita
2012
8 4S p. P78
artikel
878 Exome sequencing of extended late-onset Alzheimer's disease families identifies a variant in the TTC3 gene Zuchner, Stephan
2012
8 4S p. P679
artikel
879 Explaining the age-dependent association between hypertension and cognition in older adults: Selection and duration Power, Melinda
2012
8 4S p. P147-P148
artikel
880 Exploratory analysis of seven confirmed risk factors for Alzheimer's disease with disease progression Ruiz, Agustín
2012
8 4S p. P721-P722
artikel
881 Exploring novel cognitive outcomes for clinical trials in MCI and Alzheimer's disease compared with the ADAS-Cog Marsico, Mark
2012
8 4S p. P365
artikel
882 Exploring the biomarker cascade model: Relating cortical volume loss to [11C]PiB, [18F]FDG and MMSE over time in Alzheimer's disease patients and normal controls Adriaanse, Sofie
2012
8 4S p. P32
artikel
883 Exploring the biomarker cascade model: Relating cortical volume loss to [11C]PIB, [18F]FDG and MMSE over time in Alzheimer's disease patients and normal controls Adriaanse, Sofie
2012
8 4S p. P348
artikel
884 Exploring the functional connectivity of senior fallers Hsu, Chun Liang
2012
8 4S p. P510
artikel
885 Exposure to an enriched environment accelerates brain amyloid plaque formation but rescues spatial memory in APP-PS1 mice Montarolo, Francesca
2012
8 4S p. P652
artikel
886 Expression and characterization of a novel Aβ oligomer and fibril conformer-specific single-chain variable fragment (scFv) that was selected using Aβ1-16 linear sequence Funke, Susanne
2012
8 4S p. P706
artikel
887 Expression of anti-Aβ single-chain antibody in skeletal muscle reduces Aβ accumulation in an Alzheimer's disease mouse model Yang, Junling
2012
8 4S p. P186-P187
artikel
888 Expression of five miRNA targets in hippocampus and cerebrospinal fluid in Alzheimer's disease Müller, Mareike
2012
8 4S p. P273
artikel
889 Expression of 8-oxoguanine DNA glycosylase 1 (OGG1) and the level of TNF-alpha, Bax and Bcl-2 proteins in the brain of a double transgenic mouse model of Alzheimer's disease Dorszewska, Jolanta
2012
8 4S p. P307
artikel
890 Expression of suppressor of cytokine signaling (SOCS) genes in Alzheimer's disease brains Walker, Douglas
2012
8 4S p. P300
artikel
891 Extensive amyloid pathology in remote brain regions may predict hypometabolism in functionally connected brain regions with minor amyloid pathology: An Alzheimer's disease study Klupp, Elisabeth
2012
8 4S p. P633
artikel
892 Extracellular domain of p75NTR attenuates Beta-amyloid-induced neurotoxicity and tau hyperphosphorylation Hu, Gong-Ling
2012
8 4S p. P260
artikel
893 Extracellular mitochondrial transcription factor A (Tfam) as a potential signaling molecule that promotes inflammation and induces microglia-mediated neurotoxicity Little, Jonathan
2012
8 4S p. P301
artikel
894 Extracorporeal Aβ removal system (EARS) for Alzheimer's disease therapy: Novel devices with fragments of hollow fibers removed Aβ effectively both in vitro and in vivo Kitaguchi, Nobuya
2012
8 4S p. P189-P190
artikel
895 Eye tracking in posterior cortical atrophy: A new insight into the visual syndrome Crutch, Sebastian
2012
8 4S p. P740-P741
artikel
896 Factors associated with cognitive resilience in late life: A three-sample comparison Steinberg, Susanne
2012
8 4S p. P150-P151
artikel
897 Factors influencing time to nursing home placement in persons with probable Alzheimer's disease Nguyen, Angeline
2012
8 4S p. P374
artikel
898 Factors that influence nursing home placement in an Alzheimer's disease cohort Rountree, Susan
2012
8 4S p. P375
artikel
899 Failure analysis of dimebon using mechanistic disease modeling: Lessons for clinical development of new Alzheimer's disease therapies Geerts, Hugo
2012
8 4S p. P211
artikel
900 Fall prevention using multimedia in persons with dementia Panzer, Victoria
2012
8 4S p. P444
artikel
901 FDG metabolism in the DIAN study of autosomal dominant Alzheimer's disease Becker, John
2012
8 4S p. P245-P246
artikel
902 Field measurements of circadian light exposures, activity levels and degrees of circadian entrainment in healthy older adults and in persons with Alzheimer's disease Figueiro, Mariana
2012
8 4S p. P444-P445
artikel
903 First-in-human study of E2609, a novel BACE1 inhibitor, demonstrates prolonged reductions in plasma beta-amyloid levels after single dosing Lai, Robert
2012
8 4S p. P96
artikel
904 ‘Fit-for-purpose’ method validation of cerebrospinal fluid Alzheimer's biomarkers (Aβ38, Aβ40, Aβ42, ptau181 and total tau) Di Donato, Lorella
2012
8 4S p. P214-P215
artikel
905 Fitness is related to temporal recruitment during recall Vidoni, Eric
2012
8 4S p. P510-P511
artikel
906 FKBP51 connects tau to the systemic stress response network through Hsp90 Voss, Kellen
2012
8 4S p. P97
artikel
907 FLAP involvement in the amyloidotic phenotype of an Alzheimer's disease transgenic mouse model Chu, Jin
2012
8 4S p. P243
artikel
908 Flebogamma® DIF protects against Aβ toxicity in neuronal and endothelial cell cultures Costa, Montse
2012
8 4S p. P410-P411
artikel
909 Flutemetamol F 18 injection PET images reflect brain beta-amyloid levels Buckley, Chris
2012
8 4S p. P90
artikel
910 fMRI word repetition effects show abnormal hemispheric encoding/retrieval asymmetry in MCI Yang, Jin-Chen
2012
8 4S p. P520
artikel
911 Folate deficiency in dementia patients Ozaki, Akihiko
2012
8 4S p. P121
artikel
912 Follow up of Alzheimer's disease with psychosis genome-wide association studies Sims, Rebecca
2012
8 4S p. P676
artikel
913 Follow-up of the first American report of familial Alzheimer's disease Ghetti, Bernardino
2012
8 4S p. P665
artikel
914 For caregiver sleep: Not all stressors are created equal Bowen, Mary
2012
8 4S p. P380
artikel
915 Fractalkine signalling decreases tau pathology in tau depositing mice Nash, Kevin
2012
8 4S p. S746
artikel
916 Fractional anisotropy in the evaluation among healthy elderly, amnestic MCI and Alzheimer's disease Gang, Qi Zhi
2012
8 4S p. P164-P165
artikel
917 Framework for patient synchronization and its consequences for disease progression visualization and clinical trials Yang, Eric
2012
8 4S p. P542-P543
artikel
918 Frequency and type of medication errors by dementia caregivers Lingler, Jennifer
2012
8 4S p. P559-P560
artikel
919 Frequency of dementia and its correlates among participants in the National Early Dementia Detection Program during 2006-2009 Park, Joon Hyuk
2012
8 4S p. P499
artikel
920 From genes to hypotheses Amouyel, Philippe
2012
8 4S p. P83
artikel
921 Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: Clinical, neuroanatomical and neuropathological features Mahoney, Colin
2012
8 4S p. P92-P93
artikel
922 FTLD repeat expansions in C9orf72: Evidence for variability in the repeat sequence Pickering-Brown, Stuart
2012
8 4S p. P93
artikel
923 Fully automated BETA-AMYLOID 42 and tau assays on the enhanced chemiluminescent VITROS® ECiQ Immunodiagnostic System Baburina, Irina
2012
8 4S p. S779-S780
artikel
924 Functional analysis of a nicastrin-independent gamma-secretase complex containing an artificial double mutation in presenilin 1 Pamrén, Annelie
2012
8 4S p. P294
artikel
925 Functional and structural effects of amyloid aggregate on Xenopus laevis oocytes Parodi, Jorge
2012
8 4S p. P291-P292
artikel
926 Functional effects of the MAPT haplotypes Caffrey, Tara
2012
8 4S p. P683-P684
artikel
927 Functional examination of Hu-yi-neng, diet supplement, and its antioxidant effects on neurons WU, Shyh-Jong
2012
8 4S p. P150
artikel
928 Functional network analysis of florbetapir-low and florbetapir-high ADNI MCI subjects Carbonell, Felix
2012
8 4S p. P17
artikel
929 Functional neuroanatomical correlates of the executive clock drawing task (CLOX) performance in Alzheimer's disease: An FDG-PET study Lee, Dong Young
2012
8 4S p. P519
artikel
930 Functional neuroanatomical correlates of the executive clock drawing task (CLOX) performance in Alzheimer's disease: An FDG-PET study Lee, Dong Young
2012
8 4S p. P46
artikel
931 Functional neuroimaging of prose recall in healthy and pathological aging Johnson, David
2012
8 4S p. P511
artikel
932 GAD65, GAD67 and GABAT immunoreactivity in human brain and GAD65 loss in Alzheimer's disease Schwab, Claudia
2012
8 4S p. P410
artikel
933 Gait and cognitive function among elderly individuals with Alzheimer's disease, mild cognitive impairment (MCI) and no Alzheimer's or MCI Moon, Seok Woo
2012
8 4S p. P490
artikel
934 Gamma-secretase modulators demonstrate similar exposure-response relationship in the rat and guinea pig Lu, Yasong
2012
8 4S p. P194
artikel
935 Gamma-secretase/notch signaling in insulin resistance Gwon, A-Ryeong
2012
8 4S p. S762
artikel
936 Gastritis as a major risk factor for dementia in older adults Momtaz, Yadollah Abolfathi
2012
8 4S p. P138-P139
artikel
937 Gender differences in adherence to a home-based physical activity program in older adults with memory problems: FABS (Fitness for the Aging Brain Study) Cox, Kay
2012
8 4S p. P236
artikel
938 Gender differences in depression and daily performance in patients with Alzheimer's disease in Korea Jang, Il Mi
2012
8 4S p. P544-P545
artikel
939 Gender-specific midlife dementia risk: The differential role of long-term vascular risk factors Exalto, Lieza
2012
8 4S p. P323-P324
artikel
940 Gene combination associations with Alzheimer's disease risk and quantitative traits in the AIBL study Laws, Simon
2012
8 4S p. P678-P679
artikel
941 Gene expression analysis in the postmortem brains classified by Braak NFT-SP staging Miyashita, Akinori
2012
8 4S p. P116
artikel
942 Gene expression profiling of peripheral blood leukocytes shows upregulation of GZMB, GZMH, TGFBR3, KLRD1, KIR2DL3 and KIR2DL4 in fast Alzheimer's disease (AD)-progressors: Pilot findings Chong, Mei Sian
2012
8 4S p. P287-P288
artikel
943 Gene-gene interaction and subclinical amyloid levels in cognitively intact elderly individuals Adamczuk, Katarzyna
2012
8 4S p. P619
artikel
944 Genetic analysis of Korean early Alzheimer's and dementia patients Bagyinszky, Eva
2012
8 4S p. P668
artikel
945 Genetic association and interaction of Alzheimer's risk genes CLU, CR1, BIN1, PICALM and MS4A in a Flanders-Belgian cohort Bettens, Karolien
2012
8 4S p. P671
artikel
946 Genetic association of progressive supranuclear palsy (PSP) risk loci variants with brain gene expression and neuropathology endophenotypes Ertekin-Taner, Nilufer
2012
8 4S p. P735
artikel
947 Genetic association of variants with late-onset Alzheimer's disease risk and brain gene expression Allen, Mariet
2012
8 4S p. P451
artikel
948 Genetic complexity in the BIN1 locus Mounier, Anaïs
2012
8 4S p. P663-P664
artikel
949 Genetic risk factors for posterior cortical atrophy may be distinct from late-onset Alzheimer's disease Schott, Jonathan
2012
8 4S p. P669-P670
artikel
950 Genetic susceptibility for Alzheimer's disease: Social aspects and ethical issues Kogel, Friederike
2012
8 4S p. P563
artikel
951 Genetic variability in the cholesteryl ester transfer protein (CETP) gene may buffer the effect of APOE-ε4 on incidence of amnestic mild cognitive impairment (aMCI): Results for the Einstein Aging Study (EAS) Lipton, Richard
2012
8 4S p. P662
artikel
952 Genetic variants at MS4A4A, DNMT3B, IL1B, TOMM40, APOE and CLU related with CSF biomarkers among Finnish patients with Alzheimer's disease Elias-Sonnenschein, Lyzel
2012
8 4S p. S758
artikel
953 Gene-wide analysis of Alzheimer's disease Moskvina, Valentina
2012
8 4S p. P100-P101
artikel
954 Genome-wide association analyses of onset age in late-onset Alzheimer's disease (LOAD) demonstrate no strong effect outside of the apolipoprotein region Naj, Adam
2012
8 4S p. P662
artikel
955 Genome-wide association analysis identifies common variants associated with measures of disease progression in patients with Alzheimer's disease Newhouse, Stephen
2012
8 4S p. P101
artikel
956 Genome-wide association studies using cerebrospinal fluid biomarkers as an endophenotype for Alzheimer's disease Cruchaga, Carlos
2012
8 4S p. P232-P233
artikel
957 Genome-wide association study of Alzheimer's disease: A collaborative genetic study on Alzheimer's disease with Japan, Korea and the Alzheimer's Disease Genetics Consortium Kuwano, Ryozo
2012
8 4S p. P722-P723
artikel
958 Genome-wide association study of Alzheimer's disease with depressive symptoms Harold, Denise
2012
8 4S p. P667
artikel
959 Genome-wide association study of Alzheimer's-related brain MRI traits identifies several loci influencing degeneration of the hippocampus Melville, Scott
2012
8 4S p. P735-P736
artikel
960 Genome-wide association study using cerebrospinal fluid biomarkers beta-amyloid-42 and pTau181 in German samples of Alzheimer's disease Ramirez, Alfredo
2012
8 4S p. P663
artikel
961 Genome-wide exploration of DNA methylation in the aging brain and its relation to Alzheimer's disease De Jager, Philip
2012
8 4S p. P675-P676
artikel
962 Genome-wide screen for variants that modify the known relationship between cerebrospinal fluid Beta-Amyloid 42 and ptau levels Bailey, Matthew
2012
8 4S p. S749
artikel
963 Genomic characterization of the C9orf72 promoter repeat in FTLD and ALS patients Gijselinck, Ilse
2012
8 4S p. P683
artikel
964 Genomic damage induced by lipoproteins/cholesterol: Implications for Alzheimer's and cardiovascular disease Granic, Antoneta
2012
8 4S p. P293
artikel
965 Geographical frequency of the FTLD-ALS causing C9orf72 repeat expansion mutation in an extended cohort ascertained within the European consortium on early-onset dementia van der Zee, Julie
2012
8 4S p. P736
artikel
966 GEPT extract prevents Aβ deposition–induced synaptic loss in APPV717I transgenic mice through improving synaptophysin Shi, Jing
2012
8 4S p. P418
artikel
967 Global assessment of non-coding RNA's regulation on altered transcription in the temporal pole of late-onset Alzheimer's disease patients Humphries, Crystal
2012
8 4S p. P254
artikel
968 Glucose metabolism, gray matter structure and memory decline in subjective memory impairment Wagner, Michael
2012
8 4S p. P259
artikel
969 Good days and bad days in Alzheimer's disease: A pilot study Hamilton, Laura Mae
2012
8 4S p. P598
artikel
970 G-protein coupling to muscarinic M1 receptors is differentially affected in neurodenegerative dementias Lee, Jasinda
2012
8 4S p. P639
artikel
971 Granular tau oligomer: Intermediate of tau fibril is involved in neuronal loss Takashima, Akihiko
2012
8 4S p. P424
artikel
972 Grey and white matter changes in selected ROIs after a novel computerised cognitive intervention for MCI van Velzen, Marjolein
2012
8 4S p. S786
artikel
973 Grey-white matter contrast ratio relates to progression in mild cognitive impairment Chapman, G. William
2012
8 4S p. P258-P259
artikel
974 Group reminiscence approach with reality orientation for an old-old population with MCI in a community: The Kurihara Project Nakamura, Kei
2012
8 4S p. P571
artikel
975 Growth during adolescence and risk of Alzheimer's disease in the elderly Moceri, Victoria
2012
8 4S p. P326
artikel
976 Growth factor neuroprotection in Alzheimer's disease: Long-term effects of AAV2-BDNF gene delivery in the entorhinal cortex of non-human primates Nagahara, Alan
2012
8 4S p. P387
artikel
977 Growth hormone-releasing hormone administration in mild cognitive impairment and healthy aging increases inhibitory neurotransmitter activity in brain as measured by MR spectroscopy Baker, Laura
2012
8 4S p. S749
artikel
978 GSM treatment after the onset of Aβ deposition in mice reduces total Aβ load Flood, Dorothy
2012
8 4S p. P184
artikel
979 Guidelines for reporting clinical trial methodology research: The seven deadly sins Popp, Danielle
2012
8 4S p. P369-P370
artikel
980 Harmonization of reporting standards for studies of diagnostic test accuracy in dementia and related conditions: the STARDdem (STAndards for the Reporting of Diagnostic accuracy studies-Dementia) criteria Flicker, Leon
2012
8 4S p. P106
artikel
981 HDL cholesterol levels mediate association of CETP genotype with mortality Hall, Charles
2012
8 4S p. P495
artikel
982 Head-to-head comparison of 11C-PiB and 18F-AZD4694 for beta-amyloid imaging in aging and dementia Rowe, Christopher
2012
8 4S p. P91
artikel
983 Health care experiences of persons with dementia and their caregivers: A meta-ethnography of qualitative studies Seitz, Dallas
2012
8 4S p. P562
artikel
984 Health Resources Usage and Cost of Alzheimer's disease in a cohort of ambulatory patients registred at Bucharest Memory Center Tudose, Catalina
2012
8 4S p. S784-S785
artikel
985 Heavy episodic drinking and risk of cognitive decline in older adults Lang, Iain
2012
8 4S p. P630
artikel
986 Heightened cholinergic selective neuronal vulnerability caused by GRK5 deficiency Suo, William
2012
8 4S p. P646
artikel
987 Herpes zoster vaccine in the dementia population Tseng, Hung Fu
2012
8 4S p. S784
artikel
988 Heterogeneity of functional connectivity reductions in normal cognitive aging Lockhart, Samuel
2012
8 4S p. P68
artikel
989 Heterogeneity of functional connectivity reductions in normal cognitive aging Lockhart, Samuel
2012
8 4S p. P701-P702
artikel
990 Heterogeneity of plasma beta-amyloid species before and after treatment with solanezumab DeMattos, Ronald
2012
8 4S p. P79
artikel
991 High-dose 13.3 mg/24 h rivastigmine transdermal patch demonstrates efficacy on instrumental activities of daily living: Individual item analysis Cummings, Jeffrey
2012
8 4S p. P604
artikel
992 Higher groundwater vanadium levels are associated with better cognitive functioning in a sample of cases with diabetes mellitus: A Project FRONTIER study Edwards, Melissa
2012
8 4S p. P148
artikel
993 Higher vanadium levels differentially impacted neuropsychological functioning in cases of normal cognition and mild cognitive impairment: A project FRONTIER study Edwards, Melissa
2012
8 4S p. P316
artikel
994 High levels of BETA-AMYLOID and oxidative stress with no evidence of Alzheimer's disease-like pathology in the longest-lived rodent Edrey, Yael
2012
8 4S p. S757
artikel
995 High prevalence of cerebral microbleeds at 7T MRI in patients with early Alzheimer's disease Brundel, Manon
2012
8 4S p. P614
artikel
996 High prevalence of nocturnal hypoxia in a dementia cohort Clionsky, Emily
2012
8 4S p. S755
artikel
997 High-resolution EEG brain mapping in Alzheimer's disease Kilborn, Kerry
2012
8 4S p. P726
artikel
998 High resolution 7T MR imaging of cerebral small vessel disease Biessels, Geert Jan
2012
8 4S p. P8-P9
artikel
999 High-throughput quantitation of Alzheimer's disease neuropathologic changes via digital pathology and image analysis Neltner, Janna
2012
8 4S p. P211-P212
artikel
1000 Hilar GABAergic interneuron activity controls spatial learning and memory retrieval Andrews-Zwilling, Yaisa
2012
8 4S p. S747
artikel
                             2132 gevonden resultaten
 
   volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland